Fact-checked by Grok 2 weeks ago

Food allergy

Food allergy is an adverse immune response to specific dietary proteins, most commonly mediated by immunoglobulin E (IgE) antibodies that bind to allergens and trigger mast cell degranulation, releasing histamine and other mediators to produce symptoms ranging from localized hives and gastrointestinal upset to systemic anaphylaxis involving hypotension, airway obstruction, and potential fatality.^[1]^[2] The condition differs from food intolerances, which lack immune involvement and do not risk life-threatening reactions.^[3] IgE-mediated food allergies predominate in rapid-onset cases, with the "big eight" allergens—cow's milk, eggs, peanuts, tree nuts, soy, wheat, fish, and shellfish—accounting for over 90% of reactions in affected populations, particularly children who often outgrow milk and egg allergies but retain peanut and tree nut sensitivities into adulthood.^[4]^[5] Prevalence has risen markedly over recent decades, impacting roughly 8% of children and 10% of adults globally based on confirmed cases, though self-reported figures inflate estimates due to misattribution of non-allergic symptoms; U.S. data indicate 6.2% of adults with diagnosed food allergy as of 2021.^[6]^[7] Symptoms typically emerge within minutes to hours of exposure, encompassing skin manifestations like urticaria or angioedema, oral itching, vomiting, wheezing, and in anaphylaxis—defined by multi-organ involvement—potentially cardiovascular collapse requiring immediate epinephrine administration via auto-injector.^[8]^[9] Diagnosis relies on clinical history corroborated by skin prick testing, serum IgE levels, and oral food challenges, while management emphasizes allergen avoidance, education on cross-contamination risks, and preparedness with epinephrine; emerging oral immunotherapies show promise for desensitization but carry risks of adverse reactions.^[1] The etiology involves genetic predispositions interacting with environmental factors like delayed allergen introduction in infancy, with empirical evidence supporting early exposure guidelines to mitigate risk, though causes of the observed prevalence surge remain incompletely elucidated beyond hygiene and microbiome alterations.^[10]^[11]

Definition and Classification

IgE-Mediated Allergies

IgE-mediated food allergies constitute type I hypersensitivity reactions triggered by specific food proteins, distinguished by the involvement of immunoglobulin E (IgE) antibodies. In the sensitization phase, antigen-presenting cells process the allergen, activating Th2 lymphocytes that stimulate B cells to produce allergen-specific IgE, which binds to high-affinity FcεRI receptors on mast cells and basophils.^[12] Re-exposure to the allergen cross-links these IgE molecules, inducing immediate degranulation and release of mediators such as histamine, tryptase, leukotrienes, and prostaglandins, which drive the inflammatory response.^[13] This mechanism contrasts with subjective self-reports of food sensitivity, as true IgE-mediated allergy requires demonstrable allergen-specific IgE via tests like skin prick or serum assays, with oral food challenges providing confirmatory evidence of clinical reactivity.^[14] Symptoms manifest rapidly, typically within minutes to two hours of ingestion, encompassing cutaneous effects like urticaria and angioedema; gastrointestinal disturbances including nausea, vomiting, and crampy abdominal pain; and respiratory symptoms such as wheezing or laryngeal edema, potentially progressing to anaphylaxis in severe instances.^[15] ^[16] These acute responses arise from localized mediator effects in target organs, with systemic dissemination possible via bloodstream absorption of the allergen.^[17] Prevalence data from challenge-confirmed studies indicate IgE-mediated food allergies affect about 6% of young children, declining somewhat with age but persisting for certain allergens.^[18] Peanut allergy shows a challenge-proven rate of approximately 3% in Australian infants and 1.4% in U.S. children as of 2008, while tree nut allergy ranges from 1-3% globally, with these eliciting the majority of severe and persistent cases due to low tolerance thresholds and high anaphylaxis risk.00135-7/fulltext) ^[10] Self-reported figures often exceed these by 2-3 fold, underscoring the need for objective verification to avoid overestimation.^[19]

Non-IgE-Mediated Reactions

Non-IgE-mediated reactions to food proteins encompass a spectrum of gastrointestinal disorders driven by cell-mediated immune responses, distinct from the immediate hypersensitivity of IgE-mediated allergies. These reactions typically manifest hours to days after ingestion, involving T-cell activation and cytokine release rather than mast cell degranulation, often classified under Type IV hypersensitivity mechanisms or mixed innate-adaptive pathways.^[20]^[21] Unlike IgE-mediated processes, they lack detectable allergen-specific IgE and do not trigger systemic anaphylaxis, though severe dehydration can occur in acute episodes.^[22] The prototypical condition is food protein-induced enterocolitis syndrome (FPIES), primarily affecting infants under 6 months, with symptoms including profuse, repetitive vomiting onset 1-4 hours post-ingestion, pallor, lethargy, and occasionally hypotonicity or bloody diarrhea in chronic exposures.^[23]^[24] Common triggers include cow's milk (50-65% of cases), soy, rice, and oats, with pathophysiology linked to gut mucosal inflammation, elevated tumor necrosis factor-alpha (TNF-α), and IL-9 from peripheral blood mononuclear cells upon antigen challenge.^[25]^[26] Cohort studies report FPIES incidence at approximately 0.015-0.34% in high-risk infant populations, rarer than IgE-mediated allergies (which affect 6-8% of children), and with spontaneous resolution by age 3-5 years in 90% of cases.^[27]^[28] Other entities include food protein-induced allergic proctocolitis (FPIAP), seen in breastfed or formula-fed infants, featuring rectal bleeding and mucus in stools 1-3 weeks after trigger introduction, without systemic involvement.^[29] Predominantly triggered by cow's milk or soy via maternal diet, FPIAP reflects localized eosinophilic or lymphocytic infiltration in the colonic mucosa, resolving upon antigen elimination and rarely persisting beyond infancy.^[30] Food protein-induced enteropathy (FPE) presents with malabsorption, diarrhea, and villous atrophy resembling celiac disease, but tied to non-IgE cow's milk or soy exposure, with histological confirmation via small bowel biopsy showing intraepithelial lymphocytosis.^[31] These reactions collectively pose minimal anaphylactic risk due to absent IgE cross-linking, though acute FPIES can mimic sepsis, necessitating differentiation via timed symptom reproducibility in controlled challenges.^[32]^[33]

Distinction from Food Intolerances

Food allergies involve an aberrant immune response to food proteins, typically mediated by immunoglobulin E (IgE) antibodies that trigger mast cell degranulation and release of histamine and other mediators, leading to potential systemic effects.^[34] In contrast, food intolerances arise from non-immune mechanisms, such as enzymatic deficiencies or metabolic disturbances, without activation of the adaptive immune system or detectable IgE sensitization.^[35] For instance, lactose intolerance results from insufficient lactase enzyme activity in the small intestine, causing undigested lactose to reach the colon where bacterial fermentation produces gas and osmotic diarrhea, confined primarily to gastrointestinal effects.^[36] Diagnostic tests for allergies, including skin prick or serum IgE assays, remain negative in intolerances, underscoring the absence of immunological causality.^[37] Empirical studies using double-blind, placebo-controlled food challenges (DBPCFC), the reference standard for confirming adverse reactions, reveal frequent misattribution of intolerances as allergies in self-reports.^[38] Up to 35% of individuals self-diagnose food hypersensitivity, yet blinded challenges often fail to reproduce symptoms attributable to true allergy, instead identifying non-immune triggers like carbohydrate malabsorption.^[39] A population-based analysis found substantial discrepancies between perceived intolerance and objective DBPCFC outcomes, with many reported cases resolving as placebo effects or unrelated digestive issues upon rigorous testing.^[40] Causally, allergies propagate via antigen-specific T-cell and B-cell memory leading to rapid or delayed inflammatory cascades, whereas intolerances stem from direct physicochemical interactions, such as substrate-enzyme mismatches, yielding localized osmotic or fermentative disturbances without cytokine storms or vascular permeability changes.^[35] This distinction holds empirically, as intolerances do not elicit eosinophil recruitment or basophil activation observed in allergic responses, preventing escalation to anaphylaxis.^[3] Mislabeling risks unnecessary allergen avoidance, potentially exacerbating nutritional deficits without addressing the underlying metabolic etiology.^[41]

Historical Development

Early Observations and Recognition

The earliest documented observations of adverse food reactions trace to ancient Greece, where Hippocrates (c. 460–377 BC) described how certain foods like cheese provoked distress or death in susceptible individuals, while others consumed them harmlessly, attributing this to individual differences in bodily humors.^[42] These accounts, echoed in texts by later figures such as Lucretius, represented anecdotal idiosyncrasies rather than systematic inquiry, with no empirical framework to distinguish allergic responses from digestive upset or poisoning.^[43] Isolated reports persisted through medieval and early modern periods, including Ibn Sina's notes on food-triggered swellings and Sir John Floyer's 1698 mention of fatal shellfish reactions, yet they elicited minimal medical scrutiny amid prevailing humoral theories.^[44] By the 19th century, European dermatologists cataloged more precise instances of immediate skin eruptions post-ingestion, as Robert Willan detailed in his 1808 dermatology treatise cases of urticaria from almonds, mushrooms, fish, crabs, and mussels, sometimes escalating to fatal "urticaria febralis."00043-7/fulltext) Such descriptions aligned with emerging clinical observation but faced interpretive challenges, often conflated with infections or toxins, as allergy as a distinct entity remained undefined until Charles Richet's 1902 Nobel-recognized work on anaphylaxis in animals, which indirectly highlighted hypersensitivity risks without direct application to human food cases.^[45] Systematic study lagged, constrained by absent diagnostic standards and a focus on infectious etiologies over immune idiosyncrasies. In 1912, pediatrician Oscar M. Schloss advanced recognition through the inaugural use of scratch testing on human skin to confirm food-specific sensitivities, reporting a case where extracts of milk, egg, and wheat elicited reactions correlating with clinical symptoms in a child.^[46] Published in the American Journal of Diseases of Children, this method introduced extract-based provocation for objectivity, diverging from reliance on dietary histories alone and signaling a pivot toward testable hypotheses, though adoption was gradual amid variable reproducibility.^[47] Skepticism dominated pre-1960s discourse, with many physicians dismissing food allergies as rare psychosomatic or intolerance phenomena due to diagnostic imprecision and failure to replicate reactions under controlled conditions, leading to underreporting and therapeutic neglect.^[45] This doubt persisted even as case series accumulated, exemplified by the American Academy of Allergy's reluctance to prioritize food reactions until mechanistic validation; the 1967 identification of IgE by Kimishige and Teruko Ishizaka as the carrier of reaginic activity in allergic sera furnished the empirical cornerstone for IgE-mediated pathways, catalyzing acceptance of food allergy's immunological legitimacy.30165-8/fulltext)^[42]

Advances in Immunology and Diagnosis

The elucidation of mast cell degranulation mechanisms in the 1950s, involving histamine release triggered by allergens, laid groundwork for understanding immediate allergic responses, though full integration with antibody mediation awaited later discoveries.^[48] In 1967, Kimishige and Teruko Ishizaka identified immunoglobulin E (IgE) as the key antibody in reaginic hypersensitivity, demonstrating its role in binding to FcεRI receptors on mast cells and basophils, which upon allergen cross-linking initiate degranulation and mediator release central to IgE-mediated food allergies.^[49]^[50] This breakthrough enabled targeted models of pathophysiology, distinguishing IgE-dependent pathways from other immune responses and facilitating the development of IgE-specific diagnostics like serum-specific IgE assays.^[51] Diagnostic advancements in the 1980s and 1990s emphasized reducing reliance on skin prick tests (SPT) and radioallergosorbent tests (RAST), which exhibited high sensitivity but low specificity, often resulting in overdiagnosis of food allergies.^[45] The double-blind, placebo-controlled oral food challenge (DBPCOFC), refined during this period, became the reference standard, involving blinded administration of escalating doses under medical supervision to provoke and confirm clinical reactions, thereby validating or refuting suspected allergies with direct causal evidence.^[42]^[52] By the 2000s, standardized protocols for DBPCOFC minimized risks and improved reproducibility, addressing prior inconsistencies in open challenges and enhancing diagnostic precision beyond correlative tests alone.^[53] The 2015 Learning Early About Peanut Allergy (LEAP) study marked a paradigm shift in preventive immunology, showing via randomized controlled trial that introducing peanut protein at 4-11 months in high-risk infants (those with severe eczema or egg allergy) reduced peanut allergy development by 81% at age 5 compared to avoidance.^[54] This evidence from 640 participants challenged the avoidance-centric approach, rooted in observational data, and supported early allergen exposure as a causal preventive strategy, influencing guidelines to prioritize introduction over delay based on interventional outcomes rather than associative risks.^[55]^[56] Subsequent analyses confirmed sustained benefits, underscoring empirical validation over precautionary narratives.^[54]

Pathophysiology

Immune Mechanisms

Food allergies primarily involve IgE-mediated type I hypersensitivity reactions, where initial sensitization occurs through the processing of food allergens by antigen-presenting cells (APCs), such as dendritic cells in the gastrointestinal mucosa. In genetically predisposed atopic individuals, these APCs present allergen peptides via MHC class II to naive CD4+ T cells, promoting differentiation into Th2 cells that secrete cytokines including IL-4, IL-13, and IL-5.^[57] ^[58] IL-4 drives B cell class-switch recombination to produce allergen-specific IgE antibodies, which bind to the high-affinity FcεRI receptors on mast cells, basophils, and other effector cells.^[59] This sensitization phase establishes immunological memory, distinguishing food allergy from transient intolerances.^[57] Upon subsequent exposure to the allergen, the effector phase is triggered when multivalent food allergens cross-link IgE molecules bound to FcεRI on sensitized effector cells, initiating intracellular signaling cascades such as Lyn and Syk kinase activation.^[60] This leads to rapid degranulation, releasing preformed mediators like histamine from granules, alongside de novo synthesis of lipid mediators including leukotrienes (e.g., LTC4) and prostaglandins, and cytokines such as TNF-α and IL-4.^[61] ^[60] These mediators cause immediate effects through vasodilation, smooth muscle contraction, and increased vascular permeability, while late-phase responses involve eosinophil recruitment driven by IL-5.^[61] Epithelial barrier dysfunction plays a causal role in facilitating allergen sensitization by allowing intact or partially digested proteins to penetrate the gut mucosa, evading normal digestive degradation and tolerance induction. Studies in filaggrin-deficient mouse models and human cohorts with early-life atopic dermatitis demonstrate increased transepithelial allergen flux correlating with higher IgE sensitization rates.^[62] Human biopsy data reveal reduced tight junction proteins like zonulin in food-allergic infants, supporting "leaky gut" as an entry point for Th2-skewing antigens, particularly when combined with dysbiotic microbiota that impair regulatory T cell function.30376-4/fulltext) ^[63] Animal models further confirm that barrier disruption via detergents or genetic mutations precedes allergic priming, underscoring causality over mere correlation.^[62]

Acute and Late-Phase Responses

In IgE-mediated food allergies, the acute phase response initiates within minutes of allergen exposure upon cross-linking of allergen-specific IgE antibodies bound to FcεRI receptors on sensitized mast cells and basophils, prompting rapid degranulation.^[64] This process releases preformed mediators, including histamine, tryptase, and proteoglycans, alongside newly synthesized lipid mediators such as prostaglandin D2 and cysteinyl leukotrienes.^[64] Histamine promotes vasodilation and endothelial permeability, contributing to urticaria and angioedema, while leukotrienes induce smooth muscle contraction in the respiratory and gastrointestinal tracts, manifesting as bronchospasm or abdominal cramping.^[64] The late-phase response emerges 6 to 12 hours after the initial exposure, characterized by the recruitment of eosinophils, basophils, and T lymphocytes to the site of allergen challenge, driven by chemokines like eotaxin and cytokines such as IL-5 produced during the acute phase.^[65] Eosinophils, in particular, degranulate to release toxic granule proteins (e.g., major basic protein) and additional mediators, perpetuating tissue inflammation and potentially prolonging symptoms.^[65] Studies of cutaneous allergen challenges demonstrate this phase through persistent wheal-and-flare reactions and histological evidence of eosinophil infiltration, underscoring its role in sustained allergic inflammation.^[66] Biphasic reactions, reflecting the interplay of acute and late-phase mechanisms, occur in 1% to 20% of food allergy-induced anaphylaxis cases, with the secondary phase typically arising within hours to a day after apparent resolution of the initial symptoms.^[67] This risk, observed in clinical models of anaphylaxis, necessitates extended monitoring protocols post-exposure to mitigate recurrence, as late-phase eosinophil-mediated effects can escalate severity independently of ongoing allergen presence.^[68]

Clinical Manifestations

Common Signs and Symptoms

Cutaneous manifestations predominate as initial signs in IgE-mediated food allergic reactions, with urticaria (hives) and angioedema occurring in approximately 80-90% of acute episodes.^[69] These symptoms typically involve itchy, raised welts on the skin or deeper swelling, respectively, and may appear rapidly following allergen exposure.^[5] Gastrointestinal symptoms are also common, encompassing nausea, vomiting, abdominal pain, and diarrhea, which can occur alone or alongside skin reactions.^[5] Respiratory involvement, such as wheezing or nasal congestion, arises less frequently in non-severe cases but signals potential escalation.^[70] Symptom onset generally occurs within minutes to two hours after ingestion in IgE-mediated cases, though variability exists by reaction type and allergen; for instance, shellfish reactions manifest swiftly, often within minutes to one hour.^[71] ^[72] In non-IgE-mediated reactions, particularly to cow's milk protein, gastrointestinal symptoms like vomiting and diarrhea may be delayed, emerging 2 to 48 hours post-exposure.^[73]

Anaphylaxis and Severity

Anaphylaxis represents the most severe manifestation of food allergy, defined as an acute-onset, life-threatening systemic reaction involving the skin or mucosa plus either respiratory compromise (e.g., dyspnea, wheeze, stridor) or reduced blood pressure/end-organ dysfunction, per the National Institute of Allergy and Infectious Diseases (NIAID) and Food Allergy & Anaphylaxis Network (FAAN) consensus criteria.^[74] These criteria, validated prospectively with 97% sensitivity for emergency department anaphylaxis diagnosis, emphasize multi-system involvement to distinguish from milder reactions.^[75] In food-induced cases, symptoms often progress rapidly after ingestion, with hypotension as a hallmark of severity indicating cardiovascular collapse.^[76] Severity escalates with factors such as comorbid asthma, which elevates the relative risk of anaphylaxis by 2.07-3.29 compared to non-asthmatic individuals, particularly in severe asthma where hazard ratios reach 8.23.^[77] ^[78] Peanut and tree nut allergies demonstrate higher propensity for anaphylactic reactions than milk or egg allergies, with nuts implicated in a disproportionate share of severe pediatric cases due to potent IgE cross-linking and rapid absorption.^[79] Biphasic reactions, involving symptom recurrence without re-exposure (typically within 72 hours), occur in up to 20% of cases and predict poorer outcomes; predictors include initial hypotension, unknown triggers, and delayed epinephrine administration beyond 60 minutes.^[80] ^[81] Fatal outcomes from food anaphylaxis remain rare, with an incidence of 0.03-0.3 deaths per million person-years, though untreated severe episodes carry substantial mortality risk due to airway obstruction or shock.^[82] In analyzed cohorts, severe food anaphylaxis (grade 3-4) comprises about 28% of reactions, with 27.9% classified as high-grade including fatalities, underscoring the need for rapid intervention despite overall low lethality in treated settings.^[83] High allergen doses further amplify severity by overwhelming compensatory mechanisms, as evidenced in challenge studies.^[84]

Epidemiology

Global Prevalence and Trends

Food allergy affects approximately 8% of children and 10% of adults worldwide based on self-reported data from recent reviews, though confirmed rates via diagnostic challenges, such as oral food challenges for IgE-mediated reactions, are typically lower at around 5-6% in population studies conducted between 2019 and 2025.^[85] In the United States, diagnosed food allergy prevalence stands at 5.8% among children aged 0-17 years and 6.2% among adults as of 2021, per National Health Interview Survey data, reflecting physician-diagnosed cases rather than self-reports.^[86]^[7] These figures underscore a distinction between perceived and verified allergies, with self-reported estimates often exceeding challenge-confirmed IgE-mediated cases due to inclusion of intolerances or unverified symptoms.^[10] Prevalence varies markedly by region, with higher rates in Western countries compared to Asia and other developing areas. In Australia, self-reported food allergy affects about 10% of children, positioning it among the highest globally.^[87] In contrast, rates in Asian populations are substantially lower, often 1-2% for confirmed cases, as evidenced by comparative studies and International Study of Asthma and Allergies in Childhood (ISAAC) data showing symptom-based food allergy reports under 3% in many Asian centers.^[88] ISAAC Phase 1 surveys across multiple countries reported self-reported food-related symptoms in 2-8% of children aged 6-7 and 13-14 years, with elevated figures in affluent Western settings and lower in Asia, highlighting geographic disparities beyond diagnostic access.^[89] Trends indicate a genuine rise in prevalence, independent of improved diagnostics alone. In the US, food allergy among children increased by 50% from 3.4% in 1997-1999 to 5.1% in 2009-2011, followed by another approximate 50% rise through 2021, based on serial National Health Interview Surveys tracking parent- or physician-reported cases.^[90]^[91] Global epidemiological reviews corroborate this pattern, noting sustained increases across high-income regions since the 1990s, with meta-analyses of studies up to 2023 showing overall prevalence climbing from earlier baselines of 3% to current estimates exceeding 6% in affected populations.^[92]^[88]

Demographic Risk Factors

Food allergies demonstrate higher prevalence in children compared to adults, with estimates of approximately 4% in children and 1% in adults based on global surveys.^[93] Children represent a high-risk demographic group, though a substantial proportion outgrow specific allergies; for cow's milk allergy, up to 75% of affected children eventually resolve it, often by school age.^[94] Sex differences vary by age, with boys comprising about 64% of children diagnosed with food allergy (male-to-female ratio of 1.8:1), while in adulthood the distribution equalizes or shifts toward females (approximately 65% female).^[95] A family history of atopic disease elevates the odds of food allergy in offspring, with odds ratios of 1.8 (95% CI 1.5-2.3) for children with two or more allergic family members in population-based studies.^[96] Co-occurrence of other atopic conditions, such as eczema or asthma, further triples the risk in affected children according to cohort analyses.^[97] Food allergies in the elderly remain understudied, with limited cohort data available on prevalence or demographic patterns in this group.^[98]

Increases in Incidence

Hospitalizations for food-induced anaphylaxis among US children under 18 years old increased substantially from the late 1990s to the mid-2000s, with pediatric food allergy hospitalizations tripling during this period according to data from the National Hospital Ambulatory Medical Care Survey.^[90] Similar trends were observed in state-level registries, such as New York, where anaphylaxis hospitalizations in individuals under 20 years rose markedly from 1990 to 2006, with food allergens implicated in a growing proportion of cases following the adoption of specific ICD-9 codes in 1994.^[99] These rises reflect real immunological shifts rather than solely coding changes, as food anaphylaxis overtook other triggers in hospitalization dominance post-1994.^[100] Post-2010 analyses confirm the persistence of these upward trends. Self-reported food allergy prevalence among US children increased by 50% from 2007 to 2021, building on a prior 50% rise between 1997 and 2011, per national health surveys.^[90] Meta-analyses and epidemiological reviews indicate sustained incidence growth, with global and US data showing continued elevation in confirmed cases through the 2010s, independent of diagnostic advancements alone.^[10] Explanations attributing increases solely to improved recognition are challenged by evidence of genuine rises in immunologically verified allergies. Rates of food allergies confirmed via double-blind placebo-controlled oral food challenges, the gold standard for diagnosis, have demonstrated multi-fold increases in select cohorts from the late 1990s to early 2000s, paralleling hospitalization data.00562-4/abstract) Migration studies further support environmental contributions to these shifts, with first-generation immigrants from low-prevalence regions (e.g., Asia) to high-prevalence countries (e.g., Australia, US) exhibiting intermediate risks that converge toward host-country rates in subsequent generations, underscoring non-genetic factors in incidence escalation.^[101]^[102]

Etiology and Risk Factors

Genetic Contributions

Twin studies demonstrate substantial heritability for food allergies, with monozygotic twins showing markedly higher concordance rates than dizygotic twins, indicating a dominant genetic component. For peanut allergy specifically, pairwise concordance was 64.3% among 14 monozygotic twin pairs compared to 6.8% among 44 dizygotic pairs.^[103] Overall estimates from twin studies place food allergy heritability at approximately 80%.^[104] These findings underscore that genetic factors play a primary role, though the trait manifests through complex polygenic inheritance rather than monogenic determinism, involving multiple loci of modest effect sizes.^[105] Loss-of-function mutations in the filaggrin gene (FLG), which encodes a key epidermal barrier protein, confer increased risk for food allergies as part of the atopic march, where early skin barrier defects predispose to subsequent allergic sensitization. Children carrying FLG mutations exhibit odds ratios for food allergy ranging from 2.0 to 2.9, independent of eczema in some cohorts.01032-X/abstract) FLG variants have been consistently replicated across studies, highlighting their role in epithelial integrity and allergen penetration.^[106] Human leukocyte antigen (HLA) genes in the major histocompatibility complex also show associations with specific food allergies, influencing antigen presentation and immune response specificity. For instance, certain HLA class II alleles correlate with peanut allergy risk and anaphylaxis severity across populations, with polymorphisms in HLA binding grooves potentially tagging epitope recognition differences.^[107]^[108] Genome-wide association studies (GWAS) have identified additional loci beyond FLG and HLA, including SERPINB (involved in protease inhibition and skin barrier function), C11orf30/EMSY, and MALT1 (with the largest reported effect size, odds ratio 10.99), supporting a polygenic architecture where no single variant dominates.^[104]31574-9/fulltext) These genetic signals are modulated by non-genetic factors, as evidenced by epigenetic marks on loci like FLG, but the core predispositions remain heritable.^[106]

Environmental and Lifestyle Factors

The hygiene hypothesis posits that reduced early-life exposure to diverse microbes in sanitized modern environments disrupts immune tolerance, increasing susceptibility to allergic diseases including food allergies.^[109] Empirical evidence supports this through the protective "farm effect," where children raised on farms with animal contact and diverse microbial environments exhibit halved risk of allergic sensitization (odds ratio approximately 0.5).^[109] Similarly, farm residency correlates with lower odds of allergic rhinitis (OR 0.31, 95% CI 0.13-0.78), extending to broader atopy via enhanced regulatory T-cell responses from endotoxin-rich exposures.^[110] These associations hold after adjusting for confounders like family history, underscoring causal roles for microbial diversity over mere rural isolation.^[111] Urbanization amplifies these risks by limiting microbial contacts and correlating with higher food allergy prevalence; U.S. studies report 9.8% in urban children versus 6.2% in rural ones, a 3.5% differential attributed to diminished environmental biodiversity.^[112] Vitamin D deficiency, prevalent in urban settings due to indoor lifestyles and limited sunlight, shows inconsistent but suggestive links to elevated food allergy odds; persistently low levels yield OR 2.04 for food sensitization (95% CI 1.02-4.10), while insufficiency in sensitized infants raises allergy likelihood sixfold in select cohorts.^[113]^[114] However, systematic reviews highlight null overall associations, indicating potential confounding by sunlight exposure's independent immunomodulatory effects rather than vitamin D as sole mediator.^[115] Lifestyle practices influencing allergen timing further modulate risk; pre-2000 guidelines promoted delayed complementary feeding to avert sensitization, yet randomized controlled trials refute this, demonstrating early peanut introduction (4-11 months) slashes allergy incidence by 81% in high-risk infants.^[54] The LEAP trial's causal evidence prompted reversals in recommendations, with sustained protection into adolescence, implying avoidance historically exacerbated epidemics by forgoing oral tolerance windows.^[116] Such interventions align with causal realism, prioritizing empirical prevention over unverified delay benefits.^[11]

Specific Allergens and Sensitization Routes

The major food allergens responsible for the majority of reactions worldwide include cow's milk, egg, peanut, tree nuts (such as almond, walnut, and cashew), wheat, soy, fish, and crustacean shellfish, collectively known as the "Big 8," with sesame recognized as a ninth major allergen in recent regulatory updates.^[1] These account for approximately 90% of confirmed food allergy cases.^[90] In pediatric populations, cow's milk and egg allergies are the most prevalent, affecting 2-3% and 1-2% of infants, respectively, but are often outgrown by school age or adolescence in 80-90% of cases.^[117] In contrast, allergies to peanut, tree nuts, fish, and shellfish are more persistent, with resolution rates below 20% for peanut and tree nuts, and adult prevalence remaining stable at 1-2% for these groups.^[117]^[118] Sensitization to food allergens primarily occurs through oral exposure, which typically promotes tolerance in healthy individuals but can lead to IgE-mediated allergy under certain conditions, such as early-life disruptions in gut barrier function or microbial dysbiosis.^[119] However, cutaneous exposure via disrupted skin barriers, as in atopic dermatitis, serves as a key alternative route, driving Th2-skewed immune responses and systemic sensitization without prior oral tolerance, per the dual allergen exposure hypothesis supported by murine and human cohort studies.^[119]^[120] Inhalational sensitization is less common for initial allergy development but can provoke reactions in already sensitized individuals, particularly in occupational settings like food processing where aerosolized proteins (e.g., from fish or egg) are inhaled.^[121] Cross-contact during food preparation amplifies risks across routes, as trace amounts via skin or air can trigger responses in hypersensitive cases.^[121] Empirical evidence indicates significant cross-reactivity within allergen groups, particularly tree nuts (up to 50% co-sensitization between species like walnut and cashew due to shared storage proteins), crustacean shellfish (high tropomyosin homology leading to 75% cross-reactivity among shrimp, crab, and lobster), and fish (parvalbumin conservation causing frequent overlap).^[122]^[123] Oral allergy syndrome (OAS), affecting up to 70% of pollen-allergic individuals, exemplifies pollen-food cross-reactivity, where heat-labile profilins or lipid transfer proteins in raw fruits and vegetables (e.g., birch pollen with apple or hazelnut) elicit localized IgE responses that denature upon cooking.^[124]^[122] This cross-reactivity is clinically milder and confined to mucosal sites, distinguishing it from primary food allergies.^[124]

Diagnosis

Diagnostic Tests and Criteria

The diagnosis of IgE-mediated food allergy relies on a history of immediate-type symptoms following ingestion of a suspected food, supported by in vivo and in vitro tests to detect allergen-specific IgE sensitization, with confirmation via controlled challenge procedures.^[125] Skin prick testing (SPT) involves applying allergen extracts to the skin and pricking to assess wheal formation, offering high sensitivity (typically 85-95%) for detecting sensitization but variable specificity (often 30-60%) for predicting clinical reactions, as positive results indicate IgE presence without confirming symptomatic allergy.^[126] For common allergens like peanut, SPT wheal sizes ≥8 mm correlate with higher positive predictive values (PPV) for allergy, though false positives remain common due to asymptomatic sensitization.^[127] Serum-specific IgE (sIgE) testing quantifies IgE antibodies to food extracts, with thresholds like >0.35 kUA/L indicating sensitization but low specificity (around 38%) for clinical peanut allergy; higher cutoffs, such as sIgE ≥15 kUA/L for peanut, yield PPVs exceeding 95% in selected populations, aiding in avoiding unnecessary challenges.^[128] ^[127] Component-resolved diagnostics (CRD) enhance precision by measuring IgE to individual allergen components; for peanut, sIgE to Ara h 2 (a major storage protein) outperforms whole extract testing, with levels ≥0.35 kUA/L predicting allergy with PPV up to 92% and sensitivity around 80%, reducing reliance on challenges in high-risk cases.^[129] ^[130] The double-blind, placebo-controlled food challenge (DBPCFC) serves as the gold standard for definitive diagnosis, administering escalating doses of disguised allergen versus placebo on separate days to confirm objective symptoms at the eliciting dose while minimizing bias.^[131] Diagnostic criteria per EAACI guidelines require reproduction of typical symptoms during challenge, graded by severity (e.g., mild cutaneous to severe anaphylaxis), with open challenges acceptable for low-risk scenarios but DBPCFC preferred for objectivity in ambiguous cases.^[125] Negative challenges rule out allergy, while surrogates like SPT or sIgE guide but do not supplant this confirmatory step due to their imperfect predictive values.^[132]

Differential Diagnosis and Challenges

Food allergies must be differentiated from non-allergic food intolerances, such as lactose intolerance or histamine intolerance, which produce gastrointestinal symptoms like bloating or diarrhea without involving IgE-mediated immune responses.^[32] Unlike true allergies, intolerances lack systemic reactions like urticaria or anaphylaxis and can be confirmed through specific enzyme assays or elimination-rechallenge protocols excluding immunologic markers.^[133] Non-IgE-mediated conditions, including food protein-induced enterocolitis syndrome (FPIES), present with profuse vomiting and lethargy 1-4 hours post-ingestion, often misdiagnosed initially as acute gastroenteritis, whereas eosinophilic esophagitis (EoE) features chronic dysphagia and food impaction due to esophageal eosinophilic infiltration, distinguishable via endoscopy and biopsy rather than skin prick or serum IgE tests.^[134] Oral food challenges remain the gold standard for confirmation, as they replicate symptoms under controlled conditions to rule out psychogenic reactions or behavioral aversions mimicking allergy.^[135] Overdiagnosis arises frequently from reliance on parent-reported symptoms or unverified tests, with a 2024 UK study finding 16.1% of children with parent-reported cow's milk hypersensitivity, compared to only 3-5% confirmed prevalence in population-based oral challenge validations.^[136] This discrepancy stems from subjective interpretations of symptoms like colic or eczema, which may resolve spontaneously or stem from unrelated causes, leading to unnecessary avoidance diets that risk nutritional deficits.^[137] Diagnostic challenges include pitfalls in testing, such as commercial IgG panels, which the American Academy of Allergy, Asthma & Immunology deems invalid for identifying allergies, as elevated IgG reflects normal exposure and tolerance rather than adverse reactions.^[138] Skin prick and specific IgE tests yield false positives in up to 50-90% of cases without clinical correlation, necessitating confirmatory challenges.^[139] Cofactors like exercise exacerbate symptoms in food-dependent exercise-induced anaphylaxis, where ingestion of triggers such as wheat precedes exertion by 1-4 hours, complicating history-taking and requiring cofactor-inclusive challenges for accurate diagnosis, as reactions occur irregularly without them.^[140] These factors contribute to diagnostic delays, with FDEIA often taking years to identify due to inconsistent triggers.^[141]

Management

Acute Emergency Treatment

The primary intervention for acute anaphylaxis triggered by food allergens is immediate intramuscular administration of epinephrine, which reverses hypotension, bronchospasm, and other life-threatening effects by activating alpha- and beta-adrenergic receptors.^[142] Guidelines recommend a dose of 0.01 mg/kg (maximum 0.5 mg for adults, 0.3 mg for children) injected into the anterolateral thigh, with repeat doses every 5 to 15 minutes as necessary until response occurs.^[143] Epinephrine auto-injectors, such as EpiPen, facilitate rapid delivery outside medical settings, and patients at risk should carry them with prescribed training.^[144] Following epinephrine, supportive measures include calling emergency services, placing the patient in a supine position with legs elevated unless respiratory distress predominates, and administering supplemental oxygen, intravenous fluids for hypotension, and airway management such as intubation if obstruction develops.^[142] Adjunctive therapies like H1-antihistamines (e.g., diphenhydramine 1 mg/kg IV/IM) and systemic corticosteroids (e.g., methylprednisolone 1-2 mg/kg IV) may mitigate symptoms but do not replace epinephrine and lack evidence for reducing mortality.^[143] Bronchodilators like albuterol are indicated for wheezing unresponsive to epinephrine.^[142] Due to the risk of biphasic reactions, where symptoms recur after initial resolution, observation for at least 4 to 6 hours in a medical facility is standard, with studies indicating that over 95% of secondary reactions occur within this window if they happen at all.^[145] Case fatality rates for anaphylaxis range from 0.65% to 2%, predominantly in untreated or delayed-treatment cases, underscoring epinephrine's role in reducing mortality to near negligible levels when administered promptly.^[146] Observational data confirm that lack of early epinephrine correlates with fatal outcomes, emphasizing its causal necessity over other interventions.^[147]

Long-Term Avoidance and Monitoring

Long-term management of food allergies primarily involves strict avoidance of the implicated allergen to prevent reactions, as even trace exposures can trigger symptoms in sensitized individuals. Elimination diets require complete removal of the allergen from the diet, including hidden sources in processed foods, with patients advised to scrutinize ingredient lists and manufacturing warnings for cross-contamination risks. For instance, guidelines emphasize avoiding foods processed on shared equipment, as residual proteins can persist despite cleaning.^[148]^[149] Nutritional adequacy must be monitored through consultation with dietitians to mitigate deficiencies from prolonged restriction, particularly in children eliminating staples like milk or egg.^[150] Threshold eliciting doses underscore the need for vigilance, with empirical data showing that minute quantities suffice to provoke reactions in a subset of allergic persons. The eliciting dose affecting 5% of milk-allergic children (ED₀₅) is approximately 2.4 mg of protein, while for egg it is 2.3 mg; similarly, peanut exposures below 30 mg protein can elicit responses across allergens in dose-response studies.^[151]^[152] These low thresholds, derived from oral food challenges, justify zero-tolerance approaches over probabilistic risk assessments, as individual variability precludes safe partial exposures without testing.^[153] Periodic reassessment for tolerance is essential, especially for common pediatric allergies like milk and egg, which many children outgrow. Approximately 60-80% of young children with milk or egg allergy achieve tolerance by adolescence, prompting annual evaluations via skin prick tests, serum IgE levels, or supervised oral challenges to confirm resolution.^[154]^[155] Such re-challenges, conducted in clinical settings, allow empirical verification of outgrowing rather than reliance on waning IgE alone, enabling dietary liberalization when safe.^[156] Preventing cross-contact demands proactive education on environmental controls, including dedicated utensils, color-coded storage, and thorough surface sanitization with allergen-specific cleaners, as inadvertent transfer during preparation or dining heightens reaction risk.^[148] Patients and caregivers should be trained to recognize and mitigate these hazards in homes, schools, and eateries. Concomitantly, epinephrine auto-injectors must be carried at all times by those with anaphylaxis history, with guidelines mandating two doses for adults and appropriate weights for children to address potential biphasic reactions.^[157]^[158] Regular device checks and retraining ensure readiness, as carriage rates below 60% correlate with adverse outcomes in surveys.^[159]

Pharmacologic Options

Pharmacologic interventions for food allergy primarily target symptom modulation and reduction in reaction severity following accidental exposure, without addressing the underlying IgE-mediated immune response or providing a cure.^[160] Meta-analyses of clinical trials confirm that these agents offer only palliative benefits, with no evidence of disease modification or long-term tolerance induction.^[161] Second-generation H1-antihistamines, such as cetirizine or loratadine, are recommended for mild symptoms like urticaria, pruritus, or minor gastrointestinal upset in non-anaphylactic reactions.^[162] Randomized controlled trials (RCTs) demonstrate modest efficacy in reducing histamine-mediated effects, though limitations include incomplete blockade of severe responses and reliance on evidence from broader allergic conditions rather than food-specific challenges.^[163] Mast cell stabilizers, notably oral cromolyn sodium, serve a prophylactic role by inhibiting degranulation in some patients, particularly for gastrointestinal symptoms.^[164] However, RCTs yield mixed results, with four trials showing inconsistent symptom reduction and no robust prevention of systemic reactions, restricting use to off-label application in select cases.^[165] Omalizumab, a monoclonal anti-IgE antibody, mitigates reaction thresholds to multiple foods via subcutaneous injection every 2-4 weeks. The FDA approved it on February 16, 2024, for IgE-mediated food allergy in individuals aged 1 year and older, based on phase 3 RCTs where 16 weeks of treatment increased tolerance to peanut and other allergens compared to placebo, reducing anaphylaxis risk from accidental ingestion.^[166]^[167] Systemic corticosteroids, such as prednisone or methylprednisolone, are employed adjunctively for protracted or biphasic anaphylaxis to curb inflammation and shorten reaction duration.^[168] Systematic reviews indicate potential in preventing prolonged symptoms, though RCTs highlight variable efficacy and risks like delayed adverse effects, with no impact on initial reaction severity.^[169]

Prevention Strategies

Early Allergen Introduction

The recommendation to delay introduction of allergenic foods in infancy, once prevalent based on observational data suggesting avoidance might prevent sensitization, has been overturned by randomized controlled trials demonstrating that proactive early exposure promotes tolerance and substantially lowers allergy risk. The Learning Early About Peanut Allergy (LEAP) study, a 2015 multicenter trial involving 640 high-risk infants aged 4 to 11 months with severe eczema or egg allergy, randomized participants to either consume peanut products regularly or avoid them until age 5. Those introduced to peanuts early experienced an 81% relative reduction in peanut allergy prevalence (3.2% vs. 17.2% in the avoidance group), with sustained protection confirmed into adolescence in follow-up analyses.^[54]^[116] Complementing LEAP, the Enquiring About Tolerance (EAT) study, published in 2016, examined early introduction (from 3 months) of six allergenic foods—including peanut, egg, and cow's milk—in 1,303 infants, with per-protocol analysis showing a 67% reduction in food allergy overall among adherers, particularly pronounced for peanut (relative risk 0.25) and egg in high-risk subgroups.^[170]^[171] For egg specifically, trials like the Prevention of Egg Allergy with Tiny Amount Intake (PETIT) in 2017 demonstrated that daily heated egg consumption from 6 months in atopic dermatitis infants halved egg allergy rates at 12 months compared to controls (adjusted odds ratio 0.47).^[172] These findings underpin updated guidelines from bodies like the National Institute of Allergy and Infectious Diseases (NIAID) and American Academy of Pediatrics, which since 2017—and reaffirmed in 2023–2024—advocate introducing peanut and other top allergens (e.g., egg, sesame) around 4–6 months in all infants once developmentally ready, without prior skin testing except in select high-risk cases, extending benefits beyond peanuts to multiple allergens.^[173]^[174] Mechanistically, early oral exposure drives oral tolerance by inducing allergen-specific regulatory T cells (Tregs), which suppress Th2-driven IgE responses and promote IgG4 blocking antibodies, as evidenced in murine models and human cohorts where Treg depletion abolishes tolerance.^[175]^[176] This causal pathway contrasts with delayed exposure, which permits unchecked sensitization via skin or other routes, highlighting a first-principles shift toward leveraging the gut's tolerogenic environment in early infancy.^[177]

Dietary and Hygiene Considerations

The hygiene hypothesis posits that diminished early-life exposure to diverse microorganisms contributes to the rising prevalence of allergic diseases, including food allergies, by impairing the development of immune tolerance.^[178] This framework, evolved into the "old friends" hypothesis, emphasizes that coevolved organisms such as symbiotic bacteria, helminths, and environmental microbes—termed "old friends"—modulate immune responses to prevent atopy.^[179] Epidemiological evidence supports an inverse correlation between farm environments and allergic sensitization, with meta-analyses indicating that exposure to farm life before age one year significantly reduces the odds of atopy through mechanisms involving microbial diversity and endotoxin exposure.^[178] Similarly, helminth parasite exposure has been linked to lower rates of allergic diseases in observational studies, reflecting evolutionary adaptations where such interactions promote regulatory T-cell activity and suppress Th2-driven responses.^[180] Early dietary diversity fosters gut microbiome maturation, which empirical data associate with enhanced oral tolerance and reduced food allergy risk.^[181] Studies demonstrate that higher diversity in complementary foods, particularly fruits and vegetables at 6-9 months, correlates with a 10% lower odds of food allergy by age 10, likely via increased short-chain fatty acid production and microbial taxa like Bifidobacterium that support anti-inflammatory pathways.^[182] Gut microbiome analyses in the first 1000 days reveal that enriched diversity and specific compositions—such as higher alpha diversity—predict lower childhood food allergy incidence, underscoring causal links between dietary antigens, microbial ecology, and immune programming.^[183] Probiotic supplementation, however, yields mixed results for prevention; systematic reviews indicate limited efficacy in reducing food allergy onset, with benefits confined to symptom alleviation in established cases rather than primary prophylaxis, due to strain-specific and heterogeneous trial outcomes.^[184]^[185] Breastfeeding shows a neutral association with food allergy risk in meta-analyses of cohort studies, with no significant protective effect observed across feeding patterns in infants.^[186] In low-risk populations, durations exceeding six months may confer modest benefits against related atopic conditions like rhinitis but do not consistently prevent food allergies and could theoretically elevate risk in subsets via delayed antigen exposure.^[187] Strict maternal dietary restrictions during lactation lack empirical support for allergy prevention and are not recommended, as they fail to alter offspring sensitization rates while potentially compromising nutritional adequacy.^[188]

Controversies and Debates

Overdiagnosis and Misattribution

Self-reported food allergy rates often exceed those confirmed by objective criteria, such as oral food challenges, by a factor of approximately 2 to 3, reflecting widespread diagnostic inflation.^[189] For example, a review of studies found that confirmed food allergy was present in only about 44% of cases with a reported history consistent with allergy, indicating that self-reports overestimate true prevalence.^[189] This discrepancy arises from misattribution of non-allergic symptoms, such as gastrointestinal discomfort or skin irritations, to IgE-mediated reactions without rigorous verification.^[190] A prominent case is cow's milk allergy (CMA) in infants, where overdiagnosis is prevalent in primary care settings. In a 2024 cohort study from the BEEP trial, parent-reported cow's milk hypersensitivity affected 16.1% of infants, while primary care records indicated 11.3%, with confirmed CMA rates substantially lower, underscoring overdiagnosis driven by symptom-based attributions without challenge confirmation.^[191] Risk factors included high prescribing of low-allergy formulas in practices and maternal reports of reactions, amplifying unnecessary labels.^[136] Contributing to misattribution are unvalidated diagnostic tools, notably IgG antibody tests for food sensitivities, which lack scientific validation for identifying allergies and have been refuted by professional bodies.^[138] These tests measure normal immune exposure rather than pathological responses, and expert guidelines deem them irrelevant, as randomized evidence shows no diagnostic utility and potential for harm through false positives. Incentives such as parental anxiety over vague symptoms and promotion by alternative medicine providers further propel reliance on such tests over gold-standard challenges.^[192] Unnecessary avoidance diets resulting from overdiagnosis impose nutritional risks, particularly in children, including micronutrient deficiencies, faltering growth, and impaired development.^[193] For instance, unwarranted CMA elimination can lead to inadequate calcium and protein intake, exacerbating vulnerabilities in growing infants without allergic benefit.^[194] Rigorous challenge testing is essential to mitigate these outcomes and prevent iatrogenic harm from unsubstantiated restrictions.^[190]

Explanations for Rising Prevalence

The prevalence of food allergies has risen markedly, with challenge-proven cases in infants increasing from approximately 3% in cohorts born in the 1980s-1990s to over 10% in those born after 2000 in population-based studies from Australia and elsewhere.^[195]^[10] This trend is corroborated by a tripling of pediatric hospitalizations for food allergy between the late 1990s and mid-2000s, a period predating major refinements in diagnostic criteria like standardized oral food challenges.^[90]^[196] Explanations emphasizing improved reporting or awareness alone fail to account for the observed escalation in objective measures of severity, such as anaphylaxis admissions, which parallel prevalence shifts across generations.^[197] Migration studies provide stronger evidence for environmental causation: foreign-born children in high-prevalence nations like the United States initially show allergy rates akin to their countries of origin (often under 5%), but these rise toward host-country levels after 10 years of residence, independent of genetic heritage.^[198] Similarly, Australian children of Asian immigrant mothers born locally exhibit nut allergy rates 2-3 times higher than Asian-born migrants, highlighting modifiable exposures over inherited risk.^[199] The hygiene hypothesis, linking diminished early microbial diversity to immune dysregulation, garners empirical support through microbiome analyses revealing odds ratios of 2-4 for food allergy in infants with immature or low-diversity gut flora compared to peers.^[200]^[201] Reduced exposure to diverse pathogens—via urbanization, sanitation, and fewer siblings—correlates with this dysbiosis, fostering Th2-skewed responses that promote IgE-mediated sensitization.^[202] Correlational factors like cesarean section deliveries (odds ratio ~1.2-1.5 in large cohorts) and vitamin D insufficiency (linked to sensitization in cross-sectional data) show modest associations but lack robust causal validation, as prospective trials and adjusted analyses often attenuate effects after controlling for confounders such as maternal atopy or breastfeeding.^[203]^[204] These do not independently explain the temporal prevalence surge, unlike microbial and exposure dynamics.^[205]

Common Myths and Empirical Critiques

A persistent myth holds that food allergic reactions progressively worsen in severity with each subsequent exposure, implying a trajectory toward inevitable anaphylaxis. Empirical data refute this, demonstrating that reaction severity remains unpredictable and is not predetermined to escalate over time. No longitudinal studies support consistent worsening; instead, individual episodes vary based on dose, individual immune response, and external modulators.^[206] ^[207] ^[208] Cofactors such as exercise, alcohol ingestion, use of nonsteroidal anti-inflammatory drugs, and sleep deprivation can lower the reaction threshold or amplify symptoms in specific instances, explaining episodic variability without indicating overall progression. These elements influence basophil activation and mast cell degranulation thresholds, but their presence is sporadic, underscoring the absence of a linear severity increase. Clinical guidelines emphasize preparedness for any reaction level rather than anticipation of escalation.^[209] ^[141] ^[210] Self-diagnosis frequently conflates immunoglobulin E-mediated allergies with non-allergic intolerances or irritant responses, prompting excessive avoidance that risks nutritional deficits without addressing true pathology. Among adults reporting food allergies, self-reported prevalence reaches 9.1%, yet physician-diagnosed cases comprise only 5.3%, with confirmatory testing (e.g., oral food challenges) validating an even smaller subset. Meta-analyses of adverse food reactions reveal that while 35% of reporters perceive allergy, formal diagnosis confirms it in just 3.5%, highlighting diagnostic overreach driven by symptom misattribution rather than immunological evidence.^[211] ^[212] ^[118] Public discourse often exaggerates the scope of food allergens, citing over 170 implicated foods, yet eight principal ones—milk, egg, peanut, tree nuts, wheat, soy, fish, and crustacean shellfish—account for at least 90% of reactions in the United States. This concentration reflects epidemiological patterns from challenge-confirmed cases, not anecdotal reports, countering narratives of ubiquitous novelty allergens. Recent additions like sesame to regulatory lists (effective 2023) represent exceptions, not a broadening epidemic beyond the core group.^[90] ^[70] ^[213]

Societal and Regulatory Frameworks

Food Labeling and Trace Contaminants

The Food Allergen Labeling and Consumer Protection Act (FALCPA) of 2004 mandates that packaged foods in the United States declare the presence of any of the major food allergens—initially defined as milk, eggs, fish, tree nuts, peanuts, wheat, soybeans, and crustacean shellfish—in plain language either within the ingredients list or via a separate "Contains" statement.^[214] Sesame was added as the ninth major allergen effective January 1, 2023, following the FASTER Act of 2021, accounting for approximately 90% of food allergy reactions.^[215] The U.S. Food and Drug Administration (FDA) enforces these requirements through inspections and recall monitoring, though specific compliance rates for allergen labeling remain variably reported, with undeclared allergens frequently cited in product recalls due to cross-contact rather than labeling failures.^[214] In the European Union, Regulation (EC) No 1169/2011 requires labeling of 14 priority allergens—including cereals containing gluten, crustaceans, eggs, fish, peanuts, soybeans, milk, nuts, celery, mustard, sesame, sulphur dioxide, lupin, and molluscs—regardless of quantity, but without mandatory quantitative thresholds for declaration.^[216] Precautionary allergen labeling (PAL), such as "may contain traces," is voluntary and unregulated, leading to inconsistent application across products and manufacturers, which complicates risk assessment for consumers.^[217] Oral food challenge studies indicate that eliciting doses—the minimum amounts triggering reactions in sensitive individuals—can be as low as 1 mg of peanut protein or 2-3 mg for milk, corresponding to parts per million (ppm) levels in contaminated products, underscoring the potential risks from trace cross-contamination even below advisory label thresholds.^[218]^[219] Regulatory frameworks do not address genetically modified (GM) foods differently for allergen labeling, as empirical data spanning over 25 years of widespread GM crop consumption show no associated increase in food allergy prevalence or novel allergenicity compared to conventional counterparts.^[220]^[221] Despite early concerns about potential allergen transfer in GM development, rigorous pre-market assessments and post-market surveillance have confirmed that approved GM varieties do not elevate endogenous allergen levels or introduce new risks, with allergy rates rising concurrently across non-GM and organic food systems due to other environmental factors.^[222] Limitations persist in current labeling, as trace contaminants from shared facilities evade mandatory declaration, relying instead on variable PAL efficacy, which challenge studies suggest may not reliably correlate with actual contamination levels, prompting calls for threshold-based standards to balance consumer protection and food availability.^[219]^[223]

Public Accommodations and Policy

Policies in schools and restaurants regarding food allergies, particularly peanut and tree nut restrictions, have proliferated despite limited evidence of airborne transmission risks. Airborne exposure to peanut allergens does not typically provoke severe reactions, as confirmed by studies showing no significant allergen dispersion through ventilation systems or casual contact in shared spaces. Nut-free zones, such as dedicated tables or entire bans, aim to mitigate risks but have demonstrated mixed or negligible impacts on reaction rates; one analysis found higher epinephrine administrations for nut reactions in schools enforcing such policies compared to those without. These measures impose operational costs, including nutritional limitations and heightened anxiety among students, while empirical data indicate that most school reactions (79%) stem from ingestion rather than environmental exposure.^[224]^[225]^[226]^[227] Airline policies address food allergy risks through allowances for personal epinephrine auto-injectors and, increasingly, onboard supplies, reflecting the rarity of in-flight incidents. Allergic medical emergencies occur at a rate of approximately 0.7 per million passengers, 10-100 times lower than ground-level rates, with severe anaphylaxis even scarcer—about one per 3,600 food-allergic passengers annually. U.S. legislation enacted in 2024 mandates epinephrine auto-injectors in airline emergency kits, addressing prior reliance on vials that require medical expertise for administration, though passengers must still carry their own devices. Claims for blanket prohibitions, like nut-free flights, lack substantiation given the predominance of ingestion over inhalation triggers and minimal documented public exposures.^[228]^[225]^[229]^[230] International regulatory approaches vary, with the European Union enforcing stricter declarations for 14 allergens versus the U.S. focus on nine major ones, yet no causal link exists between such precautionary frameworks and reduced allergy prevalence. Self-reported food allergy rates in Europe range from under 1% to over 10% by region and allergen, mirroring rises in the U.S. without correlating to policy stringency; both areas report increasing incidences over decades. These disparities highlight that accommodation mandates, while promoting perceived equity, often exceed evidence-based necessities, as transmission risks remain low and prevalence trends persist independently of regulatory intensity.^[231]^[232]^[92]

Economic and Quality-of-Life Impacts

Food allergies impose substantial economic burdens on individuals, families, and society, with estimates placing the annual cost in the United States at approximately $25 billion as of recent analyses, encompassing direct medical expenses such as emergency care and diagnostics, alongside indirect costs like lost productivity and special dietary needs.^[90]^[233] This figure derives from prevalence-based modeling of physician-diagnosed cases, highlighting components like $6.8 billion in direct medical costs and the remainder in indirect societal impacts, though updated models suggest potentially higher totals exceeding $370 billion when factoring broader opportunity losses.^[234] Avoidance strategies, including specialized allergen-free products, elevate household grocery expenditures, with studies indicating gluten-free alternatives alone can cost up to 159% more than standard options, contributing to out-of-pocket family expenses averaging thousands annually per affected child.^[235] Quality-of-life impairments manifest prominently in psychological domains, with surveys of families reporting that food allergies disrupt social activities for nearly half of affected households, fostering anxiety over accidental exposure and limiting participation in communal eating events.^[236] Children experience heightened psychosocial stressors, including peer differences and fear of reactions, which correlate with elevated anxiety levels and reduced health-related quality of life compared to non-allergic peers, as evidenced by validated instruments like the Food Allergy Quality of Life Questionnaire.^[237]^[238] Caregiver productivity suffers through absenteeism for medical appointments, allergen vigilance, and reaction management, with annual lost labor costs per child estimated at over $2,800, primarily from missed workdays or reduced employment.^[239] These burdens are amplified by potential overdiagnosis, where non-IgE-mediated intolerances or misattributed symptoms prompt unnecessary avoidance regimens and interventions, inflating costs without corresponding clinical benefits and underscoring the need for rigorous diagnostic confirmation to mitigate avoidable economic strain.^[240]

Research Directions

Emerging Therapies and Trials

In February 2024, the U.S. Food and Drug Administration approved omalizumab (Xolair), an anti-IgE monoclonal antibody, as the first medication to reduce allergic reactions, including anaphylaxis, following accidental exposure to multiple foods in individuals aged 1 year and older with IgE-mediated food allergies.^[166] This approval stemmed from the phase 3 OUtMATCH trial, which demonstrated that subcutaneous omalizumab administered every 2-4 weeks for 16-20 weeks increased the cumulative tolerated dose of allergens like peanut, milk, egg, and wheat by at least 10-fold compared to placebo in 67% of treated participants versus 7% in the placebo group.^[167] A 2025 multicenter study further indicated omalizumab's superiority over oral immunotherapy in achieving higher desensitization thresholds with fewer gastrointestinal side effects, though long-term data on sustained tolerance remain limited.^[241] Oral immunotherapy (OIT) protocols for peanut allergy have shown sustained unresponsiveness rates of 50-70% in recent trials, defined as tolerating challenge doses after discontinuation, though adherence challenges persist due to frequent adverse reactions like vomiting and anaphylaxis requiring epinephrine.^[242] A 2025 phase 2 trial in children with high-threshold peanut allergy reported 68.4% achieving sustained unresponsiveness to 9,043 mg peanut protein after treatment, outperforming avoidance controls.^[243] Sublingual immunotherapy (SLIT), involving lower doses under the tongue, has emerged as a safer alternative with post-2020 trials in toddlers showing modest desensitization, such as increased tolerated peanut doses by 10-fold in 67% of participants after 12 months, with fewer systemic reactions than OIT but lower efficacy in achieving full tolerance.^[244] Ongoing SLIT studies emphasize real-food formulations to improve practicality, yet sustained unresponsiveness rates remain below 50% in most cohorts.^[245] Epicutaneous immunotherapy (EPIT) via patches like Viaskin Peanut targets skin allergen delivery to induce tolerance with minimal systemic exposure. The phase 3 PEPITES trial, reported in 2023, found 12 months of daily Viaskin Peanut 250 μg patching desensitized 35.3% of peanut-allergic children aged 4-11 years to 1,000 mg peanut protein, compared to 13.1% on placebo, with benefits persisting in open-label extensions.^[246] A 2025 three-year extension analysis confirmed progressive efficacy, with responders showing doubled tolerated doses and high adherence (over 90%), though anaphylaxis occurred in under 1% of applications; regulatory approval is pending further data on sustained effects post-discontinuation.^[247] These modalities highlight a shift toward biologics and non-oral routes to mitigate OIT's safety limitations, with combination trials underway to enhance remission rates.^[248]

Preventive Interventions and Biomarkers

Primary prevention strategies for food allergies emphasize interventions administered before allergy onset, such as early allergen introduction and microbiome-targeted approaches. Randomized controlled trials (RCTs) have extended early introduction protocols beyond peanuts to include fish and shellfish in high-risk infants, with ongoing studies evaluating their efficacy in reducing sensitization rates. For instance, a 2022 systematic review indicated that early fish exposure before 6-12 months may lower allergic rhinitis risk, though evidence for direct food allergy prevention remains limited and under investigation in prospective cohorts.^[172]^[249] Probiotics and prebiotics are in clinical pipelines for primary prevention, often tested via maternal or neonatal supplementation to modulate gut microbiota and promote immune tolerance. A 2025 review highlighted probiotics' role in altering Th2-skewed responses, with trials showing reduced IgE-mediated sensitization in infants when administered alongside breastfeeding or formula. Emerging vaccine-like constructs, including peptide- and nucleic acid-based immunotherapies, are being adapted for prophylactic use in at-risk populations, aiming to induce regulatory T-cell responses pre-allergen exposure.^[250]^[251]^[252] Microbiome modulation features prominently in 2025 research roadmaps, prioritizing scalable, low-cost interventions like synbiotics to restore dysbiotic profiles linked to allergy risk. The Food Allergy Research Roadmap outlines microbiota-targeted therapies as a priority for equitable prevention, focusing on universal applicability without socioeconomic barriers.^[253]^[250] Biomarkers for predicting allergy persistence include trajectories of allergen-specific IgE (sIgE) levels, where rising or persistently high sIgE correlates with poor prognosis and sustained reactivity. Longitudinal studies demonstrate that children with declining sIgE over time achieve resolution in up to 80% of cases for allergens like milk and egg, whereas elevated trajectories predict chronicity into adolescence. Additional markers, such as total IgE and IgG4 ratios, complement sIgE in risk stratification, enabling targeted monitoring in preventive cohorts.^[254]^[255]

References

[1]
Food Allergies - StatPearls - NCBI Bookshelf
May 5, 2025 · Food allergy results from an abnormal immune response to dietary antigens, leading to either IgE-mediated or non-IgE–mediated hypersensitivity ...Continuing Education Activity · Pathophysiology · History and Physical · Evaluation
[2]
Food allergy | Allergy, Asthma & Clinical Immunology | Full Text
Nov 10, 2011 · Food allergy is defined as an adverse immunologic response to a dietary protein. Food-related reactions are associated with a broad array of signs and symptoms.
[3]
Food Intolerance Versus Food Allergy
A food allergic reaction involves the immune system. Your immune system controls how your body defends itself. For instance, if you have an allergy to cow's ...
[4]
IgE-Mediated Food Allergies | Children's Hospital of Philadelphia
What are IgE-mediated food allergies? · Milk · Egg · Soy · Wheat · Peanut · Tree nuts · Fish · Shellfish.What are IgE-mediated food... · Testing and diagnosis · Treatment · Outlook
[5]
Food Allergy: Common Causes, Diagnosis, and Treatment
Many foods can induce an allergic reaction, but the most commonly implicated foods include cow's milk, egg, peanut, tree nut, soy, wheat, fish, and shellfish.Food Allergy: Common Causes... · Common Allergens · Oral Allergy Syndrome
[6]
Feast for thought: A comprehensive review of food allergy 2021-2023
Dec 12, 2023 · Food allergy (FA) is a major public health issue globally, affecting about 8% of children and 10% of adults (see Fig 1 for global prevalence ...
[7]
Diagnosed Allergic Conditions in Adults: United States, 2021 - CDC
Jan 26, 2023 · Data from the National Health Interview Survey. In 2021, 25.7% of adults had a seasonal allergy, 7.3% had eczema, and 6.2% had a food ...
[8]
[PDF] Managing Food Allergies in Schools | CDC
Food allergy symptoms can include. ▻ swollen lips, tongue, or eyes;. ▻ itchiness, rash, or hives;. ▻ nausea, vomiting, or diarrhea;. ▻ congestion, hoarse voice, ...
[9]
[PDF] Management Food Allergies in Schools | CDC
▻ Food allergy symptoms can include swollen lips, tongue, or eyes; ... ▻ Anaphylaxis is a severe allergic reaction that is rapid in onset and may cause ...
[10]
Epidemiology and Burden of Food Allergy - PMC - NIH
(6) This same study found that 10% of US adults reported a current food allergy, while estimates from the 2010 FDA Food Safety Survey data, estimated reported ...
[11]
https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2024-070516/204636/Guidelines-for-Early-Food-Introduction-and
[12]
Type I Hypersensitivity Reaction - StatPearls - NCBI Bookshelf - NIH
Aug 3, 2025 · The reaction occurs when antigen-specific IgE binds to mast cells and basophils, triggering the release of inflammatory mediators, including ...Introduction · History and Physical · Evaluation · Treatment / Management
[13]
Molecular mechanisms of IgE mediated food allergy - PubMed
Food allergic reactions are mostly IgE mediated and also known as immediate type hypersensitivity or type I reaction.
[14]
IgE-mediated food allergy
Sep 12, 2018 · This is typically triggered after consumption of certain fresh fruits and vegetables in pollen-allergic individuals.
[15]
Clinical manifestations of immunoglobulin E–mediated food allergy ...
Sep 1, 2020 · Cutaneous symptoms, such as acute urticaria, flushing, and angioedema, represent the most common manifestation of IgE-FA. Chronic urticaria is ...
[16]
IgE mediated food allergy - The Royal Children's Hospital
IgE-mediated reactions are characterized by stereotypical signs and symptoms that develop usually within 60 minutes of ingestion; The commonest foods implicated ...
[17]
IgE-Mediated Food Allergy - PubMed
IgE-mediated food-allergic disease differs from non-IgE-mediated disease because the pathophysiology results from activation of the immune system.
[18]
The Prevalence of IgE-Mediated Food Allergy and Other Allergic ...
Food allergy occurred in 6.4% (95% CI, 5.6-7.2) of 6-year olds and 6.3% (95% CI, 5.5-7.2) of 10-year-olds. Among infants with challenge-confirmed food allergy ...
[19]
Prevalence - Finding a Path to Safety in Food Allergy - NCBI Bookshelf
The majority of studies were based on self-reporting of tree nut allergy and yielded an overall prevalence range of 0.18 to 8.9 percent in adults and 0.0 to 3.8 ...Missing: empirical | Show results with:empirical
[20]
Pathophysiology of Non-IgE-Mediated Food Allergy - PMC
Dec 29, 2021 · In this review, we will discuss the clinical manifestations, epidemiology, pathophysiology, and management of non-IgE-mediated food allergies ...
[21]
Pathophysiology of Non-IgE-Mediated Food Allergy - PubMed
Dec 29, 2021 · Non-IgE-mediated food allergies are a group of disorders characterized by subacute or chronic inflammatory processes in the gut.
[22]
Food protein–induced enterocolitis syndrome - PMC - NIH
PATHOPHYSIOLOGY. FPIES is a non–IgE-mediated food allergy. The pathophysiology of FPIES has not been fully elucidated. However, FPIES is believed to be ...Missing: allergies | Show results with:allergies
[23]
Food Protein-Induced Enterocolitis Syndrome - PubMed
Chronic FPIES manifests with intermittent emesis, watery diarrhea, and poor growth progressing to dehydration and hypovolemic shock over a period of days to ...
[24]
Recent Update in Food Protein-Induced Enterocolitis Syndrome
Nov 21, 2022 · It can manifest as a constellation of symptoms following food ingestion, including repetitive and projectile emesis (1–4 hours), accompanied by ...
[25]
Food protein-induced enterocolitis syndrome: a review of the new ...
Feb 7, 2018 · Food protein-induced enterocolitis syndrome (FPIES) is a non IgE-mediated gastrointestinal food allergy that presents with delayed vomiting after ingestion ...
[26]
Current understanding of the immune mechanisms of food protein ...
Food protein-induced enterocolitis syndrome (FPIES) is an under-recognized and frequently misdiagnosed non-IgE-mediated food hypersensitivity disorder,Missing: allergies | Show results with:allergies
[27]
Food protein–induced enterocolitis syndrome: Increased prevalence ...
Sep 20, 2018 · It consists of gastrointestinal symptoms (persistent vomiting and, sometimes, diarrhea) and lethargy and/or pallor.<|separator|>
[28]
The evolution of food protein-induced enterocolitis syndrome (FPIES)
Sep 19, 2025 · Food protein-induced enterocolitis syndrome (FPIES) is a non-IgE-mediated food allergy characterized by delayed gastrointestinal symptoms.Missing: allergies | Show results with:allergies
[29]
Non-IgE-mediated food allergy: Evaluation and management
Apr 27, 2021 · The most common types of non-IgE-mediated food allergy are food protein-induced enterocolitis syndrome (FPIES) and food protein-induced allergic proctocolitis ...
[30]
Perspectives on Non-IgE-Mediated Gastrointestinal Food Allergy in ...
Mar 14, 2023 · This review focuses on the clinical manifestations, epidemiology, management, and recent guidelines of the most common non-IgE-mediated food hypersensitivity ...
[31]
Non-IgE-mediated food hypersensitivity - PMC - NIH
Sep 12, 2018 · It usually occurs in young infants and generally affects the entire gastrointestinal tract, manifesting as profuse emesis, diarrhea and failure ...
[32]
Food protein-induced enterocolitis syndrome (FPIES) - UpToDate
Aug 11, 2023 · Food protein-induced enterocolitis syndrome (FPIES) is a non-immunoglobulin E (IgE) mediated gastrointestinal food hypersensitivity that ...Missing: prevalence | Show results with:prevalence
[33]
Diagnostic and Management Strategies of Food Protein-Induced ...
Oct 24, 2023 · Symptoms can include vomiting, diarrhea, lethargy, hypotonia, hypotension, hypothermia, and metabolic derangements. FPIES may be sub-classified ...
[34]
Immunoglobulin E (IgE)-mediated food allergy
Dec 30, 2024 · Food allergies are broadly categorized into those mediated by food-specific IgE antibodies and those resulting from other immune mechanisms ...
[35]
Food Allergy and Intolerance: A Narrative Review on Nutritional ...
This narrative review provides an outline of the pathophysiologic and clinical features of immune and non-immune adverse reactions to food
[36]
Lactose Intolerance - StatPearls - NCBI Bookshelf
Aug 6, 2025 · Lactose intolerance is a clinical syndrome characterized by gastrointestinal symptoms following the ingestion of lactose-containing foods. In ...
[37]
Differentiating food allergies from food intolerances - PubMed
This review examines the various forms of food intolerances (immunoglobulin E [IgE] and non-IgE mediated), including celiac disease and gluten sensitivity.
[38]
A comparison of double-blind, placebo-controlled food challenge ...
Aug 4, 2023 · Double-blind, placebo-controlled food challenge (DBPCFC) remains the gold standard for diagnosing food allergy, despite sparse comparisons to open food ...
[39]
Self-Diagnosis of Food Hypersensitivity | EMJ Reviews
Mar 14, 2019 · Up to 35% of people self-diagnose food allergy or intolerance (food hypersensitivity [FH]) rather than seek a clinical diagnosis.
[40]
Articles A population study of food intolerance - ScienceDirect.com
There is a discrepancy between perception of food intolerance and the results of the double-blind placebo-controlled food challenges.
[41]
Food Hypersensitivity: Distinguishing Allergy from Intolerance, Main ...
Food allergy, a subset of food hypersensitivity, denotes an immune response to food proteins categorized into immunoglobulin IgE-mediated or non-IgE-mediated ...
[42]
History of food allergy and where we are today - PMC - NIH
May 16, 2024 · Hippocrates (460–377 BC) recorded that food could be responsible for adverse symptoms and even death.
[43]
History of Food Allergy - Karger Publishers
In this context, Hippocrates and Lucretius are quoted as first descriptors of 'idiosyncratic' reactions to food. This will be briefly discussed here. And the ...
[44]
Historical and social science perspectives on food allergy - PMC - NIH
Jun 12, 2023 · Strange reactions to foods have also been described by Ibn Sina (980–1037), Sir Thomas More (1478–1535), Sir John Floyer (1649–1734) and Henry ...
[45]
Food allergy: Past, present and future - ScienceDirect
These investigators demonstrated that food-allergic patients had significant food-specific IgE antibodies and increased numbers of intestinal mast cells in the ...
[46]
History of food allergy - PubMed
In 1912, the American pediatrician Oscar Menderson Schloss ... Milestones in the practical diagnosis of food allergy are further discussed, including scratch ...Missing: Oliver | Show results with:Oliver
[47]
Nutrition classics. American Journal of Diseases of Children, volume ...
Nutrition classics. American Journal of Diseases of Children, volume 3, 1912. A case of allergy to common foods. By Oscar M. Schloos.Missing: Oliver scratch
[48]
A brief history of allergies | National Geographic
Dec 3, 2018 · Amidst the scientific progress that characterized the 19th century, an understanding of allergies was slow to develop. In 1819, John Bostock ...
[49]
The discovery of IgE 50 years on - PMC - PubMed Central
Thus the discovery of IgE spawned thousands of studies on the science of IgE as well as on the relevance of IgE antibodies to allergic disease.
[50]
Science behind the discovery of IgE
19,20 By the mid-1960s, Drs Kimishige and Teruko Ishizaka had begun repeating some of their earlier experiments, this time by using more specific antisera for ...
[51]
Dr. Kimishige Ishizaka: 1926-2018: The discovery of IgE ... - PubMed
Dr. Kimishige Ishizaka: 1926-2018: The discovery of IgE and the revolution in the study of allergic disease. Ann Allergy Asthma Immunol.
[52]
Oral food challenges - Annals of Allergy, Asthma & Immunology
Feb 20, 2020 · Oral food challenges (OFCs) play a vital role in the diagnosis of food allergy. History, skin prick testing (SPT), and serum-specific IgE (sIgE) ...Oral Food Challenges · Abstract · Why Is The Oral Food...
[53]
Work Group report: Oral food challenge testing
The timing of the challenge is carefully chosen based on the individual patient history and the results of skin prick tests and food specific serum IgE values.
[54]
Randomized Trial of Peanut Consumption in Infants at Risk for ...
Feb 23, 2015 · The LEAP study showed that early oral introduction of peanuts could prevent allergy in high-risk, sensitized infants and in nonsensitized ...
[55]
Randomized trial of peanut consumption in infants at risk ... - PubMed
Feb 26, 2015 · Conclusions: The early introduction of peanuts significantly decreased the frequency of the development of peanut allergy among children at high ...
[56]
Early introduction of peanut reduces peanut allergy across risk ... - NIH
The Learning Early About Peanut allergy (LEAP) study has shown the effectiveness of early peanut introduction in prevention of peanut allergy (PA).
[57]
Pathogenesis of IgE-mediated food allergy and implications for ...
The key mechanism by which CD4+ T cells producing Th2 cytokines contribute to food allergy is through B-cell help and support for IgE class-switching.
[58]
The Initiation of Th2 Immunity Towards Food Allergens - PMC
This review will discuss processes and signals known to occur in Th2 responses, particularly in the context of food allergy.
[59]
Food allergy: immune mechanisms, diagnosis and immunotherapy
DC-mediated tolerance to food antigens can be reprogrammed by inflammatory stimuli to give rise to food-allergic immune responses mediated by TH2 cells, as well ...
[60]
Effector mechanisms in allergic reactions - Immunobiology - NCBI
Allergic reactions are triggered when allergens cross-link preformed IgE bound to the high-affinity receptor FcεRI on mast cells.
[61]
The Etiology of IgE-Mediated Food Allergy: Potential Therapeutics ...
Feb 13, 2025 · This includes immediate, pre-made inflammatory mediators, such as histamine and the later secretions such as newly synthesized leukotrienes, ...
[62]
The Role of Gut Microbiota and Leaky Gut in the Pathogenesis ... - NIH
Increasing evidence suggests that the balance of human gut microbiota and the integrity of our intestinal barrier may play roles in the development of FA.
[63]
Intestinal mucus barrier: a missing piece of the puzzle in food allergy
Sep 27, 2021 · We discuss the clinical relevance of the gut mucosal barrier as a site for allergic sensitization to food.
[64]
IgE and mast cells in allergic disease - PMC - PubMed Central
Antigen-induced aggregation of IgE bound to FcεRI stimulates mast cell degranulation and the release of mediators such as histamine, PGD2 and TNF, which promote ...
[65]
Eosinophils from A to Z - Gigon - 2023 - Allergy - Wiley Online Library
Apr 27, 2023 · Based on the immune mechanisms, eosinophils are mainly involved in late-phase responses of IgE-mediated and T cell-mediated hypersensitivity ...
[66]
Cutaneous Late-Phase Response in Food-Allergic Children and ...
Food hypersensitivities contribute to disease exacerbation in a sub-group of children with atopic dermatitis (AD). It has been shown that only selected ...Missing: studies | Show results with:studies
[67]
Characterizing Biphasic Food-Related Allergic Reactions Through a ...
The incidence of biphasic reactions ranges from 1% to 20%8, 9, 10, 11, 12, 13 of anaphylactic reactions, and there are several risk factors. For example, ...
[68]
Incidence and timing of biphasic anaphylactic reactions
Jul 30, 2021 · We found that 8.9% of adult patients with anaphylaxis had a biphasic reaction, but biphasic reactions together with severe abnormalities in vital signs were ...
[69]
Acute Urticaria and Anaphylaxis: Differences and Similarities in ...
Cutaneous findings of urticaria and angioedema are the most frequent manifestations (about 80–90% of anaphylaxis cases) and usually last for <24 h (72).
[70]
Food Allergies | Causes, Symptoms & Treatment | ACAAI Public ...
Allergies to milk, eggs, wheat and soy may disappear over time, while allergies to peanuts, tree nuts, fish and shellfish tend to be lifelong. Omalizumab ...Tree Nut · Peanut · Wheat & Gluten Allergy · Meat Allergy
[71]
Food allergy - Symptoms and causes - Mayo Clinic
Aug 30, 2024 · Constriction and tightening of the airways. · A swollen throat or the sensation of a lump in your throat that makes it hard to breathe. · Shock ...
[72]
Shellfish allergy - Symptoms and causes - Mayo Clinic
Jul 2, 2024 · Shellfish allergy symptoms generally start within minutes to an hour after eating or having contact with shellfish. They may include: Hives.Overview · Symptoms · Causes
[73]
Milk Allergy: Symptoms & Signs | Anaphylaxis UK
Delayed cow's milk allergy Symptoms usually start between four and 48 hours after drinking cow's milk or eating foods containing dairy. There are other types ...<|separator|>
[74]
[PDF] NIAID/FAAN Consensus Criteria for Anaphylaxis
One of the following combination of symptoms: ❑ Skin and/or Mucosa WITH Respiratory Compromise OR. ❑ Skin and/or Mucosa WITH Blood pressure or end organ.
[75]
Prospective Validation of the NIAID/FAAN Criteria for Emergency ...
Anaphylaxis diagnostic criteria were proposed at the Second Symposium on the Definition and Management of Anaphylaxis. These criteria were 97% sensitive and ...<|separator|>
[76]
Anaphylaxis definition, overview, and clinical support tool
The first sentence of the definition reads, “Anaphylaxis is a serious allergic (hypersensitivity) reaction that can progress rapidly and may cause death.” The ...
[77]
Anaphylaxis epidemiology in patients with and patients without asthma
Risk of anaphylaxis was greater in the nonsevere asthma (relative risk, 2.07; 95% CI, 1.65-2.60) and severe asthma (relative risk, 3.29; 95% CI, 2.47-3.47) ...
[78]
Food allergies and asthma - PMC - NIH
The risk of anaphylaxis was higher in those with severe asthma (hazard ratio 8.23, 6.59–10.27) as compared to those classified as having non-severe asthma ( ...
[79]
Fatal food anaphylaxis in adults and children - PMC - PubMed Central
Mar 5, 2024 · Peanuts/tree nuts were responsible in 12 and milk in 4 of the 17 fatalities in subjects < = 18 years. Levi et al. [32] described 4 cases of food ...
[80]
Time of Onset and Predictors of Biphasic Anaphylactic Reactions
Patients who present with hypotension or have an unknown inciting trigger may be at increased risk of a biphasic reaction. Clinicians should tailor observation ...
[81]
[PDF] Incidence, predictors, and treatment outcomes of biphasic ...
Common triggers of biphasic responses were foods (57.7%), drugs (31%), other known allergens (5.9%). Shellfish, edible insects, and wheat were the leading food ...
[82]
Fatal food anaphylaxis in adults and children
Mar 5, 2024 · The incidence of fatal food anaphylaxis is 0.03 to 0.3 million/people/year. Most fatal food-induced anaphylaxis occurs in the second and third decades of life.
[83]
Risk Factors for Fatal and Near‐Fatal Food Anaphylaxis: Analysis of ...
May 29, 2025 · Of the 2621 food anaphylaxis cases, 731 (27.9%) were considered as severe (grade 3, [94%] and grade 4 [6%]; 19 deaths).
[84]
Risk factors for severe reactions in food allergy - NIH
We found no consistent evidence that asthma is associated with increased severity of food‐induced reactions (i.e. any anaphylaxis) following accidental ...
[85]
Feast for thought: A comprehensive review of food allergy 2021-2023
Food allergy (FA) is a major public health issue globally, affecting about 8% of children and 10% of adults (see Fig 11, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 ...
[86]
Diagnosed Allergic Conditions in Children Aged 0–17 Years - CDC
Jan 25, 2023 · In 2021, 18.9% of children had a seasonal allergy, 10.8% had eczema, and 5.8% had a food allergy. Boys (20.0%) were more likely to have a ...
[87]
We're the 'allergy capital of the world'. But we don't know why food ...
May 30, 2024 · Research has previously suggested food allergies are more common in infants in Australia than infants living in Europe, the United States or Asia.
[88]
Food allergies around the world - Frontiers
Jun 12, 2024 · Epidemiology of food allergy. Food allergy is defined as an adverse health effect due to a specific immune response that reproducibly occurs ...Abstract · Introduction · Epidemiology of food allergy · Recent development and...
[89]
The prevalence of food allergy: A meta-analysis
Self-reported prevalence of food allergy varied from 1.2% to 17% for milk, 0.2% to 7% for egg, 0% to 2% for peanuts and fish, 0% to 10% for shellfish, and 3% to ...
[90]
Facts and Statistics - FoodAllergy.org
Food allergy reactions typically involve foods that are believed to be safe. Allergic reactions can result from mislabeling of or cross-contact with food ...
[91]
Products - Data Briefs - Number 121 - May 2013 - CDC
Among children aged 0–17 years, the prevalence of food allergies increased from 3.4% in 1997–1999 to 5.1% in 2009–2011. The prevalence of skin allergies ...Missing: 1997-2021 | Show results with:1997-2021
[92]
Epidemiology of food allergy | Allergo Journal International
Jul 9, 2025 · Epidemiological studies show an increasing prevalence worldwide, with significant regional differences. In Europe, self-reported prevalence varies widely.Epidemiology Of Food Allergy · Actual Food Allergy... · Non-Ige-Mediated Food...
[93]
Food allergy in children—the current status and the way forward - PMC
The worldwide prevalence of food allergy is estimated to be around 4% of children and 1% of adults, with an increased prevalence in the past two decades[2,4,5].
[94]
Milk - FoodAllergy.org
Most children, up to 75%, eventually outgrow a milk allergy. The allergy is most likely to continue in children who have high levels of cow's milk antibodies ...
[95]
Sex Disparity in Food Allergy: Evidence from the PubMed Database
Among children with food allergies, 64.35% were males and 35.65% were females (male/female ratio, 1.80), among adults 34.82% were males and 65.18% were females.
[96]
The Impact of Family History of Allergy on Risk of Food Allergy - MDPI
Having two or more allergic family members was more strongly predictive of food allergy in the child (OR 1.8, 95% CI 1.5–2.3).
[97]
Risk Factors for Food Allergy in Early Adolescence: The SchoolNuts ...
This study showed that male sex, Asian background, family history of allergic disease, and personal history of eczema were associated with an increased risk of ...
[98]
Food allergies in older people: An emerging health problem - PubMed
Sep 11, 2024 · The prevalence of food allergy (FA) is steadily increasing worldwide. Literature about FA in older people is very scarce since this is ...Missing: understudied | Show results with:understudied
[99]
Increasing anaphylaxis hospitalizations in the first 2 decades of life
After the widespread adoption of food anaphylaxis codes in 1994, food anaphylaxis predominated hospitalizations for anaphylaxis. Peanut was the most common food ...Missing: incidence | Show results with:incidence
[100]
Increasing anaphylaxis hospitalizations in the first 2 decades of life ...
After the widespread adoption of food anaphylaxis codes in 1994, food anaphylaxis predominated hospitalizations for anaphylaxis. Peanut was the most common food ...
[101]
How Different Parts of the World Provide New Insights Into Food ...
Feb 27, 2018 · BioMed Central Ltd. Migrant studies also suggest a strong environmental influence on food allergy risk. Du Toit et al.
[102]
The Association between Migration and Prevalence of Allergic ...
Jun 20, 2024 · Overall, migration appears to be a protective factor for allergic diseases, but the protection subsides over time and the prevalence of allergic diseases among ...
[103]
Genetics of peanut allergy: a twin study - PubMed - NIH
Among the monozygotic pairs (n = 14), 9 were concordant for peanut allergy (pairwise concordance, 64.3%) and among dizygotic pairs (n = 44), 3 were concordant ...
[104]
Genome-wide association study identifies the SERPINB gene ...
Oct 20, 2017 · We report a genome-wide association study on food allergy diagnosed by oral food challenge in 497 cases and 2387 controls.
[105]
Current Insights Into The Genetics Of Food Allergy - PMC
Of the 27 CGAS-identified genes/loci (Table 1), filaggrin (FLG) and the set of human leukocyte antigen (HLA) genes have some of the most robust evidence. Given ...
[106]
Food Allergy Genetics and Epigenetics: A Review of Genome‐Wide ...
Dec 19, 2024 · An association between FLG and FA was found in both GWAS and candidate gene studies [50, 51], first identified for peanut allergy (PA) [51] ...
[107]
HLA Polymorphisms and Food Allergy Predisposition - PMC - NIH
This review aims to unravel the potential associations between HLA gene functions and the manifestation and outcome of FA disorders.
[108]
HLA variation associated with peanut allergy and anaphylaxis ...
HLA genes located in the MHC region on chromosome 6 (6p21) are among the most consistent genetic associations with food allergy, including peanut allergy.9 ...
[109]
The “Hygiene Hypothesis” and the Lessons Learnt From Farm Studies
Mar 2, 2021 · The most consistent finding, which relates to allergic sensitization and hay fever, shows odds ratios around 0.5 suggesting halving of risk (4).Missing: living | Show results with:living
[110]
PD12 - Living on a farm protects from allergic rhinitis at school age
... odds ratio 0.31, 95% confidence interval (0.13, 0.78)). Positive associations were seen with parental allergic rhinitis (2.73 (2.12, 3.52)), food allergy ...
[111]
Urban versus Rural Residency and Allergy Prevalence among Adult ...
Apr 6, 2018 · This study supports a hypothesis that farm living is inversely associated with allergy, suggesting that environmental exposures may protect against allergy.
[112]
City Kids Much More Likely to Have Food Allergies than Rural Ones
Jun 7, 2012 · In urban centers, 9.8 percent of children have food allergies, compared to 6.2 percent in rural communities, almost a 3.5 percent difference.
[113]
Longitudinal trajectory of vitamin D status from birth to early ... - Nature
Jun 24, 2013 · However, children with persistently low vitamin D status had the highest risk of FS (odds ratio (OR) = 2.04, 95% confidence interval (CI): 1.02 ...<|separator|>
[114]
Vitamin D insufficiency is associated with challenge-proven food ...
Mar 1, 2013 · Furthermore, among infants who were food sensitized, those with vitamin D insufficiency were 6 times more likely to be food allergic than ...
[115]
Vitamin D and food allergies in children: A systematic review and ...
May 1, 2017 · Based on the studies analyzed, this systematic review did not identify a significant association between vitamin D status and food allergy.
[116]
Introducing peanut in infancy prevents peanut allergy into ... - NIH
May 28, 2024 · Researchers found that early introduction of peanut products reduced the risk of peanut allergy at age 5 by 81%. Subsequently, children from ...
[117]
Food Allergy - PMC
Of reported food allergy among adults, seafood (i.e., fish, shellfish, and mollusks) allergy is the next most common, with an estimated prevalence of 1 to 2% ...
[118]
Prevalence and Severity of Food Allergies Among US Adults
Jan 4, 2019 · This survey study provides nationally representative estimates of the distribution, severity, and factors associated with adult food allergy ...Missing: definition | Show results with:definition
[119]
The airway as a route of sensitization to peanut - NIH
Conceptually, oral exposure to peanut allergens leads to oral tolerance, whereas exposure through the skin in the absence of oral exposure leads to allergy.
[120]
An update to the dual allergen exposure hypothesis
Jun 6, 2021 · Here, we propose the airway as an alternative route of sensitization in the dual allergen exposure hypothesis that leads to food allergy.
[121]
Food hypersensitivity by inhalation - PMC - PubMed Central - NIH
Mechanisms of reactions by inhalation Food allergic reactions by inhalation occur in subjects who are already sensitized to the food, generally by ingestion. ...
[122]
Common food allergens and cross-reactivity - PMC - NIH
Sep 1, 2020 · However, certain groups of food allergens, such as tree nuts, fish, and shellfish, are associated with high rates of clinical cross-reactivity.
[123]
Food allergens: Clinical aspects of cross-reactivity - UpToDate
May 6, 2024 · Tree nuts, fish, and shellfish are more commonly clinically cross-reactive. Caution and possible allergy testing (including oral food ...
[124]
Oral Allergy Syndrome Symptoms, Diagnosis & Treatment | AAAAI
In the case of pollen and foods, the result of cross-reactivity is called Oral Allergy Syndrome (OAS) also known as Pollen Food Allergy Syndrome (PFAS). OAS is ...
[125]
EAACI guidelines on the diagnosis of IgE-mediated food allergy
Oct 10, 2023 · This European Academy of Allergy and Clinical Immunology guideline provides recommendations for diagnosing IgE-mediated food allergy
[126]
Systematic review and meta‐analyses on the accuracy of diagnostic ...
Nov 27, 2023 · Skin prick test (SPT) with fresh cow's milk and raw egg had high sensitivity (90% and 94%) for milk and cooked egg allergies. Specific IgE (sIgE) ...
[127]
Diagnosing peanut allergy with skin prick and specific IgE testing
These data suggest that a skin prick result ≥ 8 mm or a specific IgE ≥ 15 kU A /L have a high predictive value for clinical allergy to peanut.Skin Prick And Serum... · Skin Prick Testing · Serum Specific IgeMissing: thresholds | Show results with:thresholds
[128]
Serologic measurements for peanut allergy
Jan 23, 2024 · Evaluation of peanut specific IgE (sIgE) (n = 30 studies) at a threshold of more than 0.35 kUA/L revealed a Sn of 95% with a Sp of 38%.Basophil Activation Testing · Epitope-Specific Ige Assays · Diagnosis And Severity Risk...
[129]
Increasing the accuracy of peanut allergy diagnosis by using Ara h 2
Ara h 2 is the dominant peanut allergen detected in 90% to 100% of patients with peanut allergy and could help improve diagnosis. Objectives. We sought to ...
[130]
Accurate Prediction of Peanut Allergy in One-Third of Adults Using a ...
Peanut allergy can be predicted accurately in one-third of adults using a validated cutoff level of sIgE to Ara h 2.
[131]
The dilemma of open or double‐blind food challenges in diagnosing ...
The double‐blind placebo‐controlled food challenge (DBPCFC) has been regarded as the 'gold standard' for decades. However, DBPCFCs are costly, and time‐ and ...
[132]
Development and validation of a standardized double-blind ...
Jan 26, 2018 · The double-blind, placebo-controlled food challenge (DBPCFC) is considered the gold standard for food allergy diagnosis. This is however not ...
[133]
Differential diagnosis of food protein-induced enterocolitis syndrome
The symptomatic similarities of allergic eosinophilic esophagitis (EoE) with chronic FPIES are postprandial vomiting, diarrhea, occasional blood loss, iron ...
[134]
Food Protein-Induced Enterocolitis (FPIES) | Symptoms & Treatment
Food Protein Induced Enterocolitis Syndrome (FPIES) is a type of non-IgE mediated food allergy that can present with severe vomiting, diarrhea and dehydration.
[135]
Food protein-induced enterocolitis syndrome: a review of the new ...
Feb 7, 2018 · The differential diagnosis for chronic FPIES may include eosinophilic gastroenteropathies, celiac disease, and inflammatory bowel disorders ( ...
[136]
Prevalence and risk factors for milk allergy overdiagnosis in ... - NIH
Jun 20, 2024 · CMA overdiagnosis was common: 16.1% had parent‐reported cow's milk hypersensitivity, 11.3% primary care recorded milk hypersensitivity and 8.7% ...
[137]
Food Allergy Prevalence, Diagnosis and Impact: Unexpected Findings
Feb 3, 2025 · The first issue is that food allergy diagnosis is difficult, so this health condition is susceptible to overdiagnosis. This is shown in the ...
[138]
The myth of IgG food panel testing | AAAAI
The presence of IgG is likely a normal response of the immune system to exposure to food. In fact, higher levels of IgG4 to foods may simply be associated with ...
[139]
Novel diagnostics in food allergy
Diagnosis of food allergy relies on clinical history, IgE sensitization tests, and oral food challenge. Component testing and identification of optimal cutoffs ...
[140]
Food allergies and food-induced anaphylaxis: role of cofactors - PMC
In fact, exercise reportedly plays a role as a cofactor in approximately 3%–10% of anaphylactic reactions. A recent study investigated how often cofactors play ...
[141]
Cofactors in food anaphylaxis in adults
Mar 21, 2023 · Exercise, NSAIDs, alcohol, and sleep deprivation are the most frequent cofactors involved in food anaphylaxis in adults and probably act by ...
[142]
Anaphylaxis: Recognition and Management - AAFP
Sep 15, 2020 · Acute management of anaphylaxis involves removal of the trigger; early administration of intramuscular epinephrine; supportive care for the ...
[143]
Emergency treatment of anaphylaxis: concise clinical guidance - PMC
Intramuscular adrenaline is the most important treatment, although, even in healthcare settings, many patients do not receive this intervention contrary to ...
[144]
Epinephrine for First-aid Management of Anaphylaxis | Pediatrics
Mar 1, 2017 · Guidelines recommend prompt epinephrine injection for the sudden onset of any anaphylaxis symptoms after exposure to an allergen that previously ...
[145]
Duration of Observation for Detecting a Biphasic Reaction ... - PubMed
Conclusions: An observation time of ≥6 h after resolution of an initial anaphylaxis symptom can exclude recurrence of a secondary reaction in > 95% of patients.
[146]
Case Fatality and Population Mortality Associated with Anaphylaxis ...
Estimates of anaphylaxis-related mortality have been between 0.5 and 5.5 per million population, with death reportedly occurring in 0.65% to 2% of patients ...
[147]
Is epinephrine truly lifesaving, and can we prove this?
Apr 17, 2023 · Epinephrine is touted as “life-saving,” in particular because observational studies have identified lack of prompt epinephrine treatment as a critical risk ...Missing: untreated | Show results with:untreated
[148]
Avoiding Cross-Contact - FoodAllergy.org
Learn how to prevent cross-contact, which happens when an allergen is accidentally transferred from one food to another.
[149]
Elimination Diets - StatPearls - NCBI Bookshelf
Jan 9, 2024 · With most elimination diets, removal of all or a subset of the most commonly implicated food allergens is recommended; these allergens include ...
[150]
Elimination diet in food allergy: friend or foe? - PMC - PubMed Central
Oct 31, 2023 · An elimination diet for at least two weeks is recommended for IgE-mediated manifestations before the oral food challenge under medical ...
[151]
Cow's milk and egg protein threshold dose distributions in ... - NIH
Jun 13, 2022 · The respective Eliciting Dose 05 (ED05) is 2.4 mg for milk and 2.3 mg for egg. As about 70% children allergic to such foods may tolerate them ...
[152]
Eliciting Dose and Safety Outcomes From a Large Dataset of ...
Sep 20, 2018 · Our data show that the ED50 across all allergens is below 30 mg of protein; therefore safety in challenges may be increased by including ...<|separator|>
[153]
Identifying thresholds of reaction for different foods - PMC - NIH
However, ∼50% of patients with peanut allergy are reported to tolerate > 120 mg of peanut protein. Thus, if this threshold is known, then many patients can ...
[154]
Likelihood of Child Outgrowing Food Allergy Depends of Type ...
Jul 26, 2013 · About 60 to 80 percent of young children with a milk or egg allergy are able to have those foods without a reaction by the time they reach age ...Missing: periodic re-
[155]
Natural course of IgE-mediated food allergy in children - PMC - NIH
Cow's milk, hen's eggs, and wheat allergies in young children have a more favorable prognosis with a relatively early outgrow, while allergies to peanuts, tree ...Missing: periodic | Show results with:periodic
[156]
Baked milk and egg diets revisited
Dec 25, 2023 · Children with milk and egg allergy frequently tolerate milk and egg in baked products, and these children are outgrowing their allergy.
[157]
Epinephrine Options and Training - FoodAllergy.org
Epinephrine injection, USP auto-injector 0.3 mg with the yellow label is for people who weigh more than 66 pounds.
[158]
International recommendations on epinephrine auto-injector doses ...
Dec 5, 2022 · Children under 15 kg with food allergy may be at risk of having epinephrine auto-injectors administered into bone. Allergy Asthma Clin ...
[159]
Improving epinephrine autoinjector usability and carriage frequency ...
Sep 23, 2022 · Although epinephrine autoinjectors (EAIs) are crucial for the management of anaphylaxis, patient carriage frequency of EAI is as low as 57% ...
[160]
Update on clinical research for food allergy treatment - PMC - NIH
Jul 14, 2023 · There have been advancements in FA treatment in recent years with multiple clinical trials utilizing novel and innovative therapeutic strategies.
[161]
Food Allergies Treatment & Management - Medscape Reference
May 13, 2024 · There are currently no curative therapies for food allergy. ... The prevalence of food allergy: a meta-analysis. J Allergy Clin ...Missing: options cure
[162]
Evidence-based use of antihistamines for treatment of allergic ...
Jul 28, 2023 · Available since the 1940s, H1 antihistamines are mainstay treatments for allergic conditions such as allergic rhinitis and urticaria.
[163]
Acute and long‐term management of food allergy: systematic review
Nov 12, 2013 · H1-antihistamines may be of benefit, but this evidence was in part derived from studies on those with cross-reactive birch pollen allergy.Managing Acute Reactions · Longer-Term Management · Allergen-Specific...
[164]
Cromolyn Sodium - StatPearls - NCBI Bookshelf
Oct 28, 2024 · ... cromolyn sodium is FDA-approved for asthma prophylaxis, allergic rhinitis, and mast cell diseases, with off-label uses for food allergies ...
[165]
The effectiveness of oral sodium cromoglycate in the treatment of ...
Aug 9, 2025 · There were mixed findings about mast cell stabilizers used prophylactically for food allergy symptoms. Four randomized trials and two ...
[166]
FDA Approves First Medication to Help Reduce Allergic Reactions to ...
Feb 16, 2024 · Xolair is the first FDA-approved medication to reduce allergic reactions to more than one type of food after accidental exposure.
[167]
Omalizumab for the Treatment of Multiple Food Allergies
Feb 25, 2024 · Omalizumab treatment for 16 weeks was superior to placebo in increasing the reaction threshold for peanut and other common food allergens.
[168]
Treatment for food allergy: Current status and unmet needs
Aug 20, 2022 · The treatment of food allergy has traditionally relied on avoidance of the offending food(s) and use of emergency medications in the event ...
[169]
Evidence update for the treatment of anaphylaxis - ScienceDirect.com
Corticosteroids may help prevent or shorten protracted reactions. ... food anaphylaxis in people with food allergy: a systematic review and meta-analysis.
[170]
Randomized Trial of Introduction of Allergenic Foods in Breast-Fed ...
Mar 4, 2016 · Observational studies suggest that the early introduction of peanut, egg, or cow's milk may prevent the development of allergy to these foods.
[171]
Early Introduction of Other Top Allergens - FoodAllergy.org
In 2019, a new analysis of EAT study data showed that early introduction of allergenic foods did protect against food allergy for some children at high risk.
[172]
Early Introduction of Allergenic Foods and the Prevention of ... - NIH
Jun 21, 2022 · In 2017, the Prevention of Egg Allergy with Tiny Amount Intake Trial (PETIT) randomized 147 infants with atopic dermatitis to consume either ...
[173]
[PDF] Preventing Food Allergies in Infants: - FoodAllergyPrevention.org
According to NIAID guidelines, most infants should begin early peanut introduction at home. These infants can be fed infant-safe peanut foods when they are ...
[174]
Primary prevention of food allergy: beyond early introduction
Dec 19, 2024 · Most infant feeding guidelines focus on the importance of early introduction of allergenic foods in infants at around age 4–6 months.<|separator|>
[175]
Immune Mechanisms of Food Allergy and its Prevention by Early ...
Sep 9, 2017 · Thus, allergy to ovalbumin can be transferred by injecting Th2 effector cells from an allergic mouse into a naive mouse [9]. On the other hand, ...
[176]
The clinical and immunological basis of early food introduction in ...
Natural Treg cells inhibit different effector cells and the production of allergen sIgE and they induce IgG4 by Br1 cells which further blocks IgE activity via ...
[177]
Regulatory Immune Mechanisms in Tolerance to Food Allergy - PMC
Dec 12, 2018 · Similar to Treg cells, B regulatory cells (Breg cells) suppress effector T cells and contribute to the immune tolerance to food allergens.
[178]
The hygiene hypothesis for allergy – conception and evolution
The present paper reviews the historical roots of the “hygiene hypothesis” and charts its development over more than 30 years.
[179]
Old Friends Hypothesis - News-Medical
In 2008, Grammatikos expanded this hypothesis to include symbiotic bacteria and parasites as "old friends" that may assist in the function of the immune system.
[180]
Unraveling the Hygiene Hypothesis of helminthes and autoimmunity
Apr 13, 2015 · The Hygiene Hypothesis (HH) attributes the dramatic increase in autoimmune and allergic diseases observed in recent decades in Western ...
[181]
Diet Diversity Through the Life-Course as an Opportunity Toward ...
Recent findings suggest that an early exposure to diverse food antigens may promote the development of immune tolerance. Accordingly, diet diversity during the ...
[182]
Diet Diversity, Gut Microbiome and Prevention of Allergic Diseases
Sep 5, 2023 · 53 reported (UK) that fruit and vegetable diversity at 6 and 9 months significantly reduced the odds of food allergy by 10 years of age. 3. Food ...
[183]
Gut microbiome in the first 1000 days and risk for childhood food ...
Mar 15, 2024 · To summarize recent data on the association between gut microbiome composition and food allergy (FA) in early childhood and highlight ...
[184]
Study Highlights New Data on Probiotics as Food Allergy Treatment ...
Jan 17, 2025 · A recent systematic review concluded that evidence was mixed on the efficacy of probiotics for pediatric food allergies , with findings ...
[185]
[PDF] Probiotics, prebiotics and food allergy: a review
However, the evidence supporting probiotics for preventing food allergies lacks robustness. Current ev- idence supports the use of oligosaccharides from breast ...<|control11|><|separator|>
[186]
Can exclusive breastfeeding in the first 4 months reduce food allergy?
Recently, a large systematic review and meta-analysis of 68 studies15 found no significant association between infants' feeding patterns and FAs. However, this ...
[187]
Breastfeeding and risk of food allergy and allergic rhinitis in offspring
May 21, 2024 · Breastfeeding for more than 6 months proves to be an effective preventive measure against AR. However, it potentially elevates the risk of FA in children.
[188]
Dietary strategies for early immune modulation in primary food ...
Dec 7, 2023 · Maternal food allergen avoidance during pregnancy and lactation is not effective. However, maternal consumption of food allergens during breast ...<|separator|>
[189]
The future of food allergy: Challenging existing paradigms of clinical ...
May 2, 2023 · However, parental- and self-report significantly overestimate the rate of food allergy. For example, a recent review concluded that confirmed ...
[190]
A food allergy epidemic… or just another case of overdiagnosis?
Feb 17, 2021 · When we review prevalence data for food allergy, we see a familiar pattern—sharp increases in softer indicators of allergy such as self-report, ...
[191]
Prevalence and risk factors for milk allergy overdiagnosis in the ...
Jun 20, 2024 · CMA overdiagnosis was common: 16.1% had parent-reported cow's milk hypersensitivity, 11.3% primary care recorded milk hypersensitivity and 8.7% ...
[192]
[PDF] Why Do People Misdiagnose Themselves with Food ... - EMJ
Up to 35% of people self-diagnose food allergy or intolerance (food hypersensitivity [FH]), or diagnose it in their child, and self-manage the condition ...Missing: overdiagnosis | Show results with:overdiagnosis<|separator|>
[193]
Over- or Underdiagnosis of Cow's Milk Allergy: Is the CoMiSSTM ...
Jan 4, 2024 · These include a detrimental impact on the child's health, such as faltering growth, an increased risk of micronutrient deficiencies, poor sleep, ...
[194]
Growth and Nutritional Concerns in Children with Food Allergy - NIH
We report here findings from previous studies suggesting impairment of growth and nutritional deficiencies due to elimination diets for food allergy.Missing: unnecessary | Show results with:unnecessary
[195]
Prevalence of challenge-proven IgE-mediated food allergy using ...
The prevalence of challenge-proven peanut allergy was 3.0% (95% CI, 2.4-3.8); raw egg allergy, 8.9% (95% CI, 7.8-10.0); and sesame allergy, 0.8% (95% CI, 0.5- ...Missing: empirical | Show results with:empirical<|separator|>
[196]
Food Allergy Among U.S. Children - CDC
Oct 10, 2008 · Hospital discharges with a diagnosis related to food allergy increased significantly over time from 1998-2000 through 2004-2006.
[197]
Food allergy: is prevalence increasing? - PubMed
It is generally accepted that the prevalence of food allergy has been increasing in recent decades, particularly in westernised countries.
[198]
Prevalence of Allergic Disease in Foreign-Born American Children
Children born outside the United States have a lower prevalence allergic disease that increases after residing in the United States for 1 decade.<|separator|>
[199]
Migration clue to nut allergy - Murdoch Children's Research Institute
Feb 16, 2016 · Australian-born children with Asian mothers have higher rates of nut allergy than Asian-born children who migrate to Australia, new research has found.
[200]
Food Allergy and the Microbiome: Current Understandings ... - NIH
Dec 1, 2020 · Growing evidence points to an important role for commensal microbiota in susceptibility to food allergy.
[201]
Gut Microbiota Maturity Mediates the Protective Effect of Siblings on ...
Dec 1, 2024 · A more mature microbiota at age 1 year, but not at age 1 and 6 months, was associated with reduced risk of developing food allergy (odds ratio ...
[202]
What is causing the rise in food allergy? A narrative review of risk ...
The primary intervenable risk factor identified to date is avoiding common allergens early in life. There is a hypothesis that changing recommendations about ...
[203]
Mode of Birth Is Not Associated With Food Allergy Risk in Infants
May 18, 2022 · Neither caesarean delivery before the onset of labor, nor after the onset of labor, was associated with the risk of food allergy (aOR: 0.83, 95% ...
[204]
Role of Vitamin D in Prevention of Food Allergy in Infants - PMC - NIH
Aug 18, 2020 · The association between vitamin D and development of food allergy is contradictory. There is a potential association between lower sunlight ...
[205]
Are vitamins A and D important in the development of food allergy ...
There is mixed direct evidence linking vitamin D insufficiency with food allergy. •. Vitamin A's role in food allergy is only a hypothetical association.
[206]
Myths, facts and controversies in the diagnosis and management of ...
Jun 16, 2018 · Importantly, there are no data indicating that allergic reactions get worse with each subsequent exposure. Nor is there any evidence to suggest ...
[207]
Food Allergy Myths, Debunked
MYTH: Food allergy reactions get more severe each time they occur. TRUTH: Not really. There are many cofactors that can worsen severity.
[208]
Mythbuster – Do allergic reactions worsen with each exposure to an ...
Jan 28, 2020 · Mythbuster – Do allergic reactions worsen with each exposure to an allergen? ... FACT: The severity of an allergic reaction is unpredictable.
[209]
Cofactors in Food Anaphylaxis in Adults - PubMed
Mar 21, 2023 · Cofactors can influence reaction severity in two ways: either by reducing the reaction threshold (i.e. the dose needed to trigger any symptoms) ...
[210]
How Reaction Severity Is Affected By Cofactors And Repeat ...
The severity of allergic reactions is unpredictable and governed by many factors. Few data exist on how allergic reactions are influenced by cofactors and ...
[211]
Prevalence of self-reported food allergy in American adults and use ...
The gold standard for determining the presence of food allergy in an individual is a double-blind, placebo-controlled oral food challenge,.
[212]
Food Allergies and Intolerances: A Clinical Approach to the ...
A double-blinded, placebo-controlled crossover study by Skodje et al found that GI symptoms in patients with self-reported NCGS were higher with fructan (wheat ...
[213]
Food Allergies: What You Need to Know - FDA
Aug 16, 2024 · Know the Symptoms of Food Allergies · Hives · Flushed skin or rash · Tingling or itchy sensation in the mouth · Face, tongue, or lip swelling ...
[214]
Food Allergen Labeling and Consumer Protection Act of 2004 - FDA
Nov 29, 2022 · Food Allergen Labeling and Consumer Protection Act of 2004 (Public Law 108-282, Title II)
[215]
Food Ingredients that May Cause Allergies
In the United States, nine foods account for 90% of food allergies: milk, eggs, peanuts, tree nuts, wheat, soy, fish, crustacean shellfish, and sesame.
[216]
European Union - Food Allergens - FARRP
The 14 EU allergens are: cereals (gluten), crustaceans, egg, fish, peanut, soybeans, milk, nuts, celery, mustard, sesame, sulphur dioxide, lupin, and molluscs.
[217]
[PDF] “May contain” labelling and cross-contamination, information and ...
The current European Union legislation does not cover allergens that enter accidentally in the food (cross-contamination) during the manufacturing process.<|separator|>
[218]
Updated population minimal eliciting dose distributions for use in ...
Mar 13, 2020 · Peanut Allergen Threshold Study (PATS): novel single-dose oral food challenge study to validate eliciting doses in children with peanut allergy.
[219]
Utility of food allergy thresholds
Dec 17, 2023 · Food allergen threshold or eliciting dose is important as an endpoint in clinical trials for food allergy therapeutics. •. There is a wide ...
[220]
Twenty-eight years of GM Food and feed without harm: why not ...
Mar 12, 2024 · In fact, many GMOs have helped improve production, yield and reduced risks from chemical insecticides or fungicides. Yet there are generic calls ...
[221]
Genetically modified foods and food allergy - PMC - NIH
GM foods have not been shown to have increased allergenicity compared with conventionally grown crops. Therefore, ingesting GM foods should not be an area of ...
[222]
The allergenicity of genetically modified foods from genetically ...
Therefore, to date, at least 20 years of data on GM crops have shown that applying transgenic methods to plants does not affect the levels of allergenic ...
[223]
Challenge‐verified thresholds for allergens mandatory for labeling ...
Sep 3, 2023 · It is mandatory to label food products with the 14 main allergens (Table 1) in the EU. However, it is voluntary to add precautionary allergen ...
[224]
No evidence for belief that nut allergens spread through aircraft ...
Oct 16, 2024 · There is no evidence for the commonly held belief that nut allergens can be spread through aircraft ventilation systems, say allergy and aviation medicine ...
[225]
Flying with nut and other food allergies: unravelling fact from fiction
Given the above findings, announcements asking all passengers to refrain from eating nuts are unlikely to be effective in protecting nut-allergic passengers, ...
[226]
Nut-Free Schools: Points to Ponder - US News Health
Aug 25, 2016 · Did that first point state that food allergy reactions are actually higher in schools with nut-free policies? According to one study, yes.
[227]
Should peanut be allowed in schools? Yes - PMC - NIH
For example, according to a United States national peanut and tree nut registry, 79% of peanut and tree nut reactions in schools occurred in classrooms and only ...
[228]
How Common Are Allergic Reactions During Commercial Flights? A ...
The incidence of allergic IMEs at meta-analysis was 0.7 events per million passengers (95% CI 0.4–1.1). Reassuringly, the rate of allergic IMEs has been stable ...
[229]
Safer Skies Ahead: Congress Approves Legislation Requiring ...
May 15, 2024 · “This legislation represents a tremendous step forward for people with food allergies traveling on commercial airplanes,” said Kenneth Mendez, ...
[230]
Flying with food allergies: new review confirms commercial flights ...
Jul 22, 2025 · Serious reactions are even rarer: for every 3,600 passengers with food allergies flying in a year, only one may experience any reaction, with ...
[231]
Comparison of Food Allergen Regulations: USA, EU, and Canada
Sep 14, 2024 · The EU law requires these allergens to be clearly indicated on food packaging, ensuring that consumers are well-informed about potential risks.
[232]
Frequency of food allergy in Europe: An updated systematic review ...
Food allergy (FA) is increasingly reported in Europe, however, the latest prevalence estimates were based on studies published a decade ago.Missing: regulations | Show results with:regulations
[233]
Food Allergies Statistics By Medical Professionals and Facts (2025)
Aug 6, 2025 · Overall, food allergies impose an economic cost of approximately $24.8 billion on the U.S. economy each year, encompassing healthcare, special ...
[234]
Estimating the societal economic burden of food allergy in ... - PubMed
Sep 17, 2025 · Results: The model estimated 16,678,832 people with ≥1 physician-diagnosed FA, an annual total societal cost of $370.8 billion, and an annual ...
[235]
Why it's so expensive to eat with a food allergy - BBC
Feb 1, 2019 · Looking specifically at gluten-free foods, a 2018 UK study showed that some items cost on average 159% more than their conventional counterparts ...Missing: expense | Show results with:expense
[236]
Behavioral Health Overview and Psychological Impacts
60 percent reported that food allergies significantly affected meal preparation. 49 percent or more indicated that food allergies affected family social ...
[237]
Psychosocial issues and quality of life associated with food allergy
Children with food allergies are at risk for anxiety, feelings of isolation, and fear of situations, all of which negatively affect their FAQOL. · Parental ...
[238]
High anxiety and health-related quality of life in families with ...
Parents of children with food allergy have higher levels of anxiety and lower health-related QoL (HRQL) compared with families of children without a food ...
[239]
Economic burden of food allergy
Gupta et al,14 annual lost labor productivity was $2838.18 per child with FA, of which the largest proportion was attributable to a caregiver giving up a job, ...
[240]
The Economic Burden of Food Allergy: What We Know and What We ...
Apr 28, 2022 · The annual costs of these diets represented 4.2–9.5% of the total costs of student meals with an additional incremental cost of approximately € ...
[241]
Newsroom - Johns Hopkins Medicine
Mar 2, 2025 · Omalizumab, a US Food and Drug Administration-approved (FDA) injectable drug for food allergies, performed better than oral immunotherapy.
[242]
The Current State of Oral Immunotherapy
Peanut and milk OIT have been reported to induce sustained unresponsiveness in approximately 30 to 70+% of individuals, though a number of variables make broad ...
[243]
Peanut Oral Immunotherapy in Children with High-Threshold Peanut ...
Feb 10, 2025 · All 32 treated and 3 out of 30 avoiders (10%) tolerated 9043 mg. In the intention-to-treat analysis, sustained unresponsiveness occurred in 68.4 ...
[244]
to 4-year-old peanut-allergic children: A randomized, placebo ...
Oct 10, 2023 · Prior studies of peanut sublingual immunotherapy (SLIT) have suggested a potential advantage with younger age at treatment initiation.
[245]
The use of grocery-sourced real-food solutions in sublingual ...
Sublingual immunotherapy (SLIT) is a safe, effective therapy for the treatment of food allergy. Studies demonstrating SLIT efficacy have primarily used ...Missing: post- | Show results with:post-
[246]
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with ...
May 10, 2023 · Epicutaneous immunotherapy for 12 months was superior to placebo in desensitizing children to peanuts and increasing the peanut dose that triggered allergic ...
[247]
DBV Technologies Announces Positive 3-Year Results from ...
Jan 8, 2025 · The data provide support that continued treatment with VIASKIN Peanut showed further improvement through 36 months of treatment across all efficacy parameters.
[248]
Food allergy: emerging therapies in the twenty-first century
Jun 14, 2025 · Emerging long-term treatment approaches include biologics, such as anti-IgE therapies, and epicutaneous and sublingual immunotherapy. Short- ...
[249]
Timing of Allergenic Food Introduction to the Infant Diet and Risk of ...
Sep 20, 2016 · There was low-certainty evidence that fish introduction before age 6 to 12 months was associated with reduced allergic rhinitis and very low- ...
[250]
Gut Microbiota and Food Allergy: A Review of Mechanisms and ...
Sep 20, 2025 · Numerous clinical and preclinical studies have been conducted to investigate the role of probiotics in preventing and managing food allergies.3. Results · Table 2 · Table 3
[251]
Prevention of IgE-Mediated Food Allergy: Emerging Strategies ... - NIH
This review focuses on maternal- and neonatal-directed interventions that are being actively investigated and developed.2. Dietary Interventions · 3. Microbiome · Prebiotic, Probiotic, And...
[252]
https://pmc.ncbi.nlm.nih.gov/articles/PMC12546382/
[253]
Food Allergy Fund Launches Exclusive Research Roadmap to ...
A first-ever Food Allergy Research Roadmap, a comprehensive guide designed to accelerate medical discovery and development progress within the next five years.Missing: modulation | Show results with:modulation
[254]
Biomarkers associated with persistence and severity of IgE ...
Among eight identified biomarkers, total IgE, specific IgE (sIgE), and IgG4 were the most often cited biomarkers of persistent allergies to milk, eggs, and ...Missing: trajectories | Show results with:trajectories
[255]
Biomarkers of peanut allergy in children over time - Foong - 2024
Jun 18, 2024 · Our data demonstrates that high biomarkers in early childhood are associated with PA persistence, which is consistent with previous findings.